{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:49:11Z","timestamp":1794491351691,"version":"4.9.1"},"reference-count":327,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of the First Affiliated Hospital of Soochow University","award":["BXQN2024038"],"award-info":[{"award-number":["BXQN2024038"]}]},{"name":"Suzhou Youth Fund for Basic Research Projects","award":["SSD2025072"],"award-info":[{"award-number":["SSD2025072"]}]},{"DOI":"10.13039\/501100007129","name":"Shandong\u00a0Provincial\u00a0Natural\u00a0Science\u00a0Foundation","doi-asserted-by":"crossref","award":["ZR2023QH365, ZR2024MH230"],"award-info":[{"award-number":["ZR2023QH365, ZR2024MH230"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Shandong\u00a0Provincial\u00a0Natural\u00a0Science\u00a0Foundation","doi-asserted-by":"crossref","award":["ZR2023QH249"],"award-info":[{"award-number":["ZR2023QH249"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82503702"],"award-info":[{"award-number":["82503702"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82300219"],"award-info":[{"award-number":["82300219"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02924-x","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:05:42Z","timestamp":1778285142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CELF family of RNA-binding proteins: roles in disease biology and potential for therapeutic intervention"],"prefix":"10.1186","volume":"24","author":[{"given":"Yukang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aobo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunshu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangling","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wancheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"issue":"1","key":"2924_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/wrna.107","volume":"3","author":"T Dasgupta","year":"2012","unstructured":"Dasgupta T, Ladd AN. The importance of CELF control: molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteins. Wiley Interdiscip Rev RNA. 2012;3(1):104\u201321.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"2924_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106525","volume":"197","author":"S Peng","year":"2024","unstructured":"Peng S, et al. The role of CELF family in neurodevelopment and neurodevelopmental disorders. Neurobiol Dis. 2024;197:106525.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"2924_CR3","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1128\/MCB.21.4.1285-1296.2001","volume":"21","author":"AN Ladd","year":"2001","unstructured":"Ladd AN, Charlet N, Cooper TA. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol Cell Biol. 2001;21(4):1285\u201396.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"2924_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/dvdy.23959","volume":"242","author":"Y Blech-Hermoni","year":"2013","unstructured":"Blech-Hermoni Y, Stillwagon SJ, Ladd AN. Diversity and conservation of CELF1 and CELF2 RNA and protein expression patterns during embryonic development. Dev Dyn. 2013;242(6):767\u201377.","journal-title":"Dev Dyn"},{"issue":"4","key":"2924_CR5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4161\/rna.7.4.12345","volume":"7","author":"JM Gallo","year":"2010","unstructured":"Gallo JM, Spickett C. The role of CELF proteins in neurological disorders. RNA Biol. 2010;7(4):474\u20139.","journal-title":"RNA Biol"},{"key":"2924_CR6","unstructured":"Uhl\u00e9n M, FL, Hallstr\u00f6m BM, et al. Brain tissue expression of CELF3 \u2013 Summary. 2025. Available from: https:\/\/www.proteinatlas.org\/ENSG00000159409-CELF3\/brain."},{"key":"2924_CR7","unstructured":"Uhl\u00e9n M, FL, Hallstr\u00f6m BM, et al. Brain expression of CELF5. 2025. Available from: https:\/\/www.proteinatlas.org\/ENSG00000161082-CELF5\/brain."},{"key":"2924_CR8","unstructured":"Uhl\u00e9n M, FL, Hallstr\u00f6m BM, et al. Brain tissue expression of CELF2 \u2013 Summary. 2025. Available from: https:\/\/v19.proteinatlas.org\/ENSG00000048740-CELF2\/brain."},{"key":"2924_CR9","unstructured":"Uhl\u00e9n M, FL, Hallstr\u00f6m BM, et al. Brain tissue expression of CELF4 \u2013 Summary. 2025. Available from: https:\/\/www.proteinatlas.org\/ENSG00000101489-CELF4\/brain."},{"issue":"11","key":"2924_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003067","volume":"8","author":"JL Wagnon","year":"2012","unstructured":"Wagnon JL, et al. CELF4 regulates translation and local abundance of a vast set of mRNAs, including genes associated with regulation of synaptic function. PLoS Genet. 2012;8(11):e1003067.","journal-title":"PLoS Genet"},{"issue":"14","key":"2924_CR11","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.1093\/nar\/gkt470","volume":"41","author":"JM Edwards","year":"2013","unstructured":"Edwards JM, et al. Structural insights into the targeting of mRNA GU-rich elements by the three RRMs of CELF1. Nucleic Acids Res. 2013;41(14):7153\u201366.","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"2924_CR12","doi-asserted-by":"publisher","first-page":"17756","DOI":"10.1074\/jbc.M310687200","volume":"279","author":"AN Ladd","year":"2004","unstructured":"Ladd AN, et al. CELF6, a member of the CELF family of RNA-binding proteins, regulates muscle-specific splicing enhancer-dependent alternative splicing. J Biol Chem. 2004;279(17):17756\u201364.","journal-title":"J Biol Chem"},{"issue":"9","key":"2924_CR13","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1093\/nar\/gki561","volume":"33","author":"J Han","year":"2005","unstructured":"Han J, Cooper TA. Identification of CELF splicing activation and repression domains in vivo. Nucleic Acids Res. 2005;33(9):2769\u201380.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2924_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1042\/BJ20060490","volume":"400","author":"J Marquis","year":"2006","unstructured":"Marquis J, et al. CUG-BP1\/CELF1 requires UGU-rich sequences for high-affinity binding. Biochem J. 2006;400(2):291\u2013301.","journal-title":"Biochem J"},{"issue":"10","key":"2924_CR15","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.str.2010.06.018","volume":"18","author":"M Teplova","year":"2010","unstructured":"Teplova M, et al. Structural insights into RNA recognition by the alternate-splicing regulator CUG-binding protein 1. Structure. 2010;18(10):1364\u201377.","journal-title":"Structure"},{"issue":"3","key":"2924_CR16","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/nar\/gkh275","volume":"32","author":"G Singh","year":"2004","unstructured":"Singh G, et al. ETR-3 and CELF4 protein domains required for RNA binding and splicing activity in vivo. Nucleic Acids Res. 2004;32(3):1232\u201341.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2924_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1006\/geno.2001.6558","volume":"74","author":"D Li","year":"2001","unstructured":"Li D, Bachinski LL, Roberts R. Genomic organization and isoform-specific tissue expression of human NAPOR (CUGBP2) as a candidate gene for familial arrhythmogenic right ventricular dysplasia. Genomics. 2001;74(3):396\u2013401.","journal-title":"Genomics"},{"issue":"1","key":"2924_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2091-13-6","volume":"13","author":"H Suzuki","year":"2012","unstructured":"Suzuki H, et al. Alternative splicing produces structural and functional changes in CUGBP2. BMC Biochem. 2012;13(1):6.","journal-title":"BMC Biochem"},{"issue":"15","key":"2924_CR19","doi-asserted-by":"publisher","first-page":"5151","DOI":"10.1093\/nar\/gkp546","volume":"37","author":"K Tsuda","year":"2009","unstructured":"Tsuda K, et al. Structural basis for the sequence-specific RNA-recognition mechanism of human CUG-BP1 RRM3. Nucleic Acids Res. 2009;37(15):5151\u201366.","journal-title":"Nucleic Acids Res"},{"issue":"19","key":"2924_CR20","doi-asserted-by":"publisher","first-page":"8638","DOI":"10.1093\/nar\/gkr510","volume":"39","author":"J Edwards","year":"2011","unstructured":"Edwards J, et al. Sequence determinants for the tandem recognition of UGU and CUG rich RNA elements by the two N\u2013terminal RRMs of CELF1. Nucleic Acids Res. 2011;39(19):8638\u201350.","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"2924_CR21","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1093\/nar\/gkp346","volume":"37","author":"YH Goo","year":"2009","unstructured":"Goo YH, Cooper TA. CUGBP2 directly interacts with U2 17S snRNP components and promotes U2 snRNA binding to cardiac Troponin T pre-mRNA. Nucleic Acids Res. 2009;37(13):4275\u201386.","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"2924_CR22","doi-asserted-by":"publisher","first-page":"11056","DOI":"10.3390\/ijms222011056","volume":"22","author":"M Nasiri-Aghdam","year":"2021","unstructured":"Nasiri-Aghdam M, Garcia-Gardu\u00f1o TC, Jave-Su\u00e1rez LF. CELF family proteins in cancer: highlights on the RNA-binding protein\/noncoding RNA regulatory axis. Int J Mol Sci. 2021;22(20):11056. https:\/\/doi.org\/10.3390\/ijms222011056.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2924_CR23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41598-021-03901-9","volume":"12","author":"A Kajdasz","year":"2022","unstructured":"Kajdasz A, et al. Distribution of alternative untranslated regions within the mRNA of the CELF1 splicing factor affects its expression. Sci Rep. 2022;12(1):190.","journal-title":"Sci Rep"},{"issue":"Pt 16","key":"2924_CR24","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1242\/jcs.01194","volume":"117","author":"AN Ladd","year":"2004","unstructured":"Ladd AN, Cooper TA. Multiple domains control the subcellular localization and activity of ETR-3, a regulator of nuclear and cytoplasmic RNA processing events. J Cell Sci. 2004;117(Pt 16):3519\u201329.","journal-title":"J Cell Sci"},{"issue":"6\u20137","key":"2924_CR25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.bbagrm.2013.01.001","volume":"1829","author":"I Vlasova-St Louis","year":"2013","unstructured":"Vlasova-St Louis I, et al. CELFish ways to modulate mRNA decay. Biochim Biophys Acta. 2013;1829(6\u20137):695\u2013707.","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"2924_CR26","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1016\/j.celrep.2019.08.022","volume":"28","author":"R Chatrikhi","year":"2019","unstructured":"Chatrikhi R, et al. RNA binding protein CELF2 regulates signal-induced alternative polyadenylation by competing with enhancers of the polyadenylation machinery. Cell Rep. 2019;28(11):2795-2806.e3.","journal-title":"Cell Rep"},{"key":"2924_CR27","doi-asserted-by":"crossref","unstructured":"Nasiri-Aghdam M, Garcia-Gardu\u00f1o TC, Jave-Su\u00e1rez LF. CELF family proteins in cancer: highlights on the RNA-binding protein\/noncoding RNA regulatory axis. Int J Mol Sci. 2021;22(20):11056.","DOI":"10.3390\/ijms222011056"},{"key":"2924_CR28","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.mcn.2012.12.003","volume":"56","author":"AN Ladd","year":"2013","unstructured":"Ladd AN. CUG-BP, Elav-like family (CELF)-mediated alternative splicing regulation in the brain during health and disease. Mol Cell Neurosci. 2013;56:456\u201364.","journal-title":"Mol Cell Neurosci"},{"issue":"10","key":"2924_CR29","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1093\/hmg\/ddaa095","volume":"29","author":"DC Cox","year":"2020","unstructured":"Cox DC, et al. Increased nuclear but not cytoplasmic activities of CELF1 protein leads to muscle wasting. Hum Mol Genet. 2020;29(10):1729\u201344.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2924_CR30","doi-asserted-by":"publisher","first-page":"35550","DOI":"10.1038\/srep35550","volume":"6","author":"J Giudice","year":"2016","unstructured":"Giudice J, et al. Neonatal cardiac dysfunction and transcriptome changes caused by the absence of Celf1. Sci Rep. 2016;6(1):35550.","journal-title":"Sci Rep"},{"issue":"1","key":"2924_CR31","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.1038\/s41467-023-41730-8","volume":"14","author":"I Salamon","year":"2023","unstructured":"Salamon I, et al. CELF4 controls mRNA translation underlying synaptic development in the prenatal mammalian neocortex. Nat Commun. 2023;14(1):6025.","journal-title":"Nat Commun"},{"issue":"45","key":"2924_CR32","doi-asserted-by":"publisher","first-page":"7106","DOI":"10.1038\/s41388-019-0936-x","volume":"38","author":"L Piqu\u00e9","year":"2019","unstructured":"Piqu\u00e9 L, et al. Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer. Oncogene. 2019;38(45):7106\u201312.","journal-title":"Oncogene"},{"key":"2924_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123585","volume":"370","author":"S Dong","year":"2025","unstructured":"Dong S, et al. CELF2 inhibits bladder cancer progression by decreasing the stability of CXCL5. Life Sci. 2025;370:123585.","journal-title":"Life Sci"},{"issue":"15","key":"2924_CR34","doi-asserted-by":"publisher","first-page":"7559","DOI":"10.1111\/jcmm.16791","volume":"25","author":"L Wang","year":"2021","unstructured":"Wang L, et al. CELF2 is a candidate prognostic and immunotherapy biomarker in triple-negative breast cancer and lung squamous cell carcinoma: A pan-cancer analysis. J Cell Mol Med. 2021;25(15):7559\u201374.","journal-title":"J Cell Mol Med"},{"key":"2924_CR35","doi-asserted-by":"crossref","unstructured":"Li J, et al. Role of CELF2 in ferroptosis: potential targets for cancer therapy (Review). Int J Mol Med. 2023;52(4):88.","DOI":"10.3892\/ijmm.2023.5291"},{"issue":"1","key":"2924_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/ijd.17295","volume":"64","author":"B Sah","year":"2025","unstructured":"Sah B, et al. Loss of CELF2 promotes skin tumorigenesis and increases drug resistance. Int J Dermatol. 2025;64(1):101\u201310.","journal-title":"Int J Dermatol"},{"issue":"1","key":"2924_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1475-2867-13-115","volume":"13","author":"LN Wu","year":"2013","unstructured":"Wu LN, et al. Si-RNA mediated knockdown of CELF1 gene suppressed the proliferation of human lung cancer cells. Cancer Cell Int. 2013;13(1):115.","journal-title":"Cancer Cell Int"},{"issue":"11","key":"2924_CR38","first-page":"11254","volume":"9","author":"H Wang","year":"2016","unstructured":"Wang H, et al. CELF1 promotes colorectal cancer proliferation and chemoresistance via activating the MAPK signaling pathway. Int J Clin Exp Pathol. 2016;9(11):11254\u201361.","journal-title":"Int J Clin Exp Pathol"},{"key":"2924_CR39","doi-asserted-by":"crossref","unstructured":"Chaudhury A, et al. CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT. Nat Commun. 2016;7(1):13362.","DOI":"10.1038\/ncomms13362"},{"issue":"14","key":"2924_CR40","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1128\/MCB.25.14.6267-6278.2005","volume":"25","author":"AN Ladd","year":"2005","unstructured":"Ladd AN, et al. Cardiac tissue-specific repression of CELF activity disrupts alternative splicing and causes cardiomyopathy. Mol Cell Biol. 2005;25(14):6267\u201378.","journal-title":"Mol Cell Biol"},{"issue":"10","key":"2924_CR41","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1161\/CIRCRESAHA.117.311281","volume":"121","author":"KT Chang","year":"2017","unstructured":"Chang KT, et al. CELF1 mediates connexin 43 mRNA degradation in dilated cardiomyopathy. Circ Res. 2017;121(10):1140\u201352.","journal-title":"Circ Res"},{"issue":"49","key":"2924_CR42","doi-asserted-by":"publisher","first-page":"35372","DOI":"10.1074\/jbc.M113.507426","volume":"288","author":"SK Verma","year":"2013","unstructured":"Verma SK, et al. Reactivation of fetal splicing programs in diabetic hearts is mediated by protein kinase C signaling. J Biol Chem. 2013;288(49):35372\u201386.","journal-title":"J Biol Chem"},{"issue":"1","key":"2924_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-024-00556-y","volume":"29","author":"WJ Qin","year":"2024","unstructured":"Qin WJ, et al. Curriculum vitae of CUG binding protein 1 (CELF1) in homeostasis and diseases: a systematic review. Cell Mol Biol Lett. 2024;29(1):32.","journal-title":"Cell Mol Biol Lett"},{"issue":"14","key":"2924_CR44","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/cne.25520","volume":"531","author":"E Grlickova-Duzevik","year":"2023","unstructured":"Grlickova-Duzevik E, et al. Members of the CUGBP Elav-like family of RNA-binding proteins are expressed in distinct populations of primary sensory neurons. J Comp Neurol. 2023;531(14):1425\u201342.","journal-title":"J Comp Neurol"},{"issue":"5","key":"2924_CR45","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.biochi.2005.10.011","volume":"88","author":"C Barreau","year":"2006","unstructured":"Barreau C, et al. Mammalian CELF\/Bruno-like RNA-binding proteins: molecular characteristics and biological functions. Biochimie. 2006;88(5):515\u201325.","journal-title":"Biochimie"},{"key":"2924_CR46","doi-asserted-by":"crossref","unstructured":"Beisang D, Bohjanen PR, Vlasova-St Louis I. CELF1, a Multifunctional Regulator of Posttranscriptional Networks. Binding Protein, 2012.","DOI":"10.5772\/48780"},{"issue":"1","key":"2924_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13578-022-00844-0","volume":"12","author":"S Lai","year":"2022","unstructured":"Lai S, et al. N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer. Cell Biosci. 2022;12(1):125.","journal-title":"Cell Biosci"},{"key":"2924_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fnmol.2013.00057","volume":"6","author":"ML Caillet-Boudin","year":"2014","unstructured":"Caillet-Boudin ML, et al. Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy. Front Mol Neurosci. 2014;6:57.","journal-title":"Front Mol Neurosci"},{"key":"2924_CR49","unstructured":"MapMyGenome. CELF3 Gene: Function, Role in Disease, and Research. 2025. Available from: https:\/\/learn.mapmygenome.in\/celf3."},{"issue":"23","key":"2924_CR50","doi-asserted-by":"publisher","first-page":"15383","DOI":"10.3390\/ijms232315383","volume":"23","author":"A Corsi","year":"2022","unstructured":"Corsi A, et al. Tau Isoforms: Gaining Insight into MAPT Alternative Splicing. Int J Mol Sci. 2022;23(23):15383.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2924_CR51","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/mrd.20742","volume":"74","author":"A Dev","year":"2007","unstructured":"Dev A, et al. Mice deficient for RNA-binding protein brunol1 show reduction of spermatogenesis but are fertile. Mol Reprod Dev. 2007;74(11):1456\u201364.","journal-title":"Mol Reprod Dev"},{"issue":"3","key":"2924_CR52","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jds.2021.11.011","volume":"17","author":"X Meng","year":"2022","unstructured":"Meng X, Wang W, Wang X. MicroRNA-34a and microRNA-146a target CELF3 and suppress the osteogenic differentiation of periodontal ligament stem cells under cyclic mechanical stretch. J Dent Sci. 2022;17(3):1281\u201391.","journal-title":"J Dent Sci"},{"issue":"1","key":"2924_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2023.102090","volume":"35","author":"E Alors-P\u00e9rez","year":"2024","unstructured":"Alors-P\u00e9rez E, et al. Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response. Mol Ther Nucleic Acids. 2024;35(1):102090.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"2924_CR54","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1387\/ijdb.082685jw","volume":"54","author":"J Wu","year":"2010","unstructured":"Wu J, et al. Differential expression of the Brunol\/CELF family genes during Xenopus laevis early development. Int J Dev Biol. 2010;54(1):209\u201314.","journal-title":"Int J Dev Biol"},{"key":"2924_CR55","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3389\/fgene.2019.01380","volume":"10","author":"R Huang","year":"2019","unstructured":"Huang R, et al. Germ Cell-Specific Gene 1-Like Protein Regulated by Splicing Factor CUGBP Elav-Like Family Member 5 and Primary Bile Acid Biosynthesis are Prognostic in Glioblastoma Multiforme. Front Genet. 2019;10:1380.","journal-title":"Front Genet"},{"issue":"4","key":"2924_CR56","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1007\/s00429-015-1005-z","volume":"221","author":"SE Maloney","year":"2016","unstructured":"Maloney SE, Khangura E, Dougherty JD. The RNA-binding protein Celf6 is highly expressed in diencephalic nuclei and neuromodulatory cell populations of the mouse brain. Brain Struct Funct. 2016;221(4):1809\u201331.","journal-title":"Brain Struct Funct"},{"issue":"8","key":"2924_CR57","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1002\/dvdy.21209","volume":"236","author":"KR Brimacombe","year":"2007","unstructured":"Brimacombe KR, Ladd AN. Cloning and embryonic expression patterns of the chicken CELF family. Dev Dyn. 2007;236(8):2216\u201324.","journal-title":"Dev Dyn"},{"issue":"5","key":"2924_CR58","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1101\/gad.207654.112","volume":"27","author":"J Dalal","year":"2013","unstructured":"Dalal J, et al. Translational profiling of hypocretin neurons identifies candidate molecules for sleep regulation. Genes Dev. 2013;27(5):565\u201378.","journal-title":"Genes Dev"},{"issue":"7","key":"2924_CR59","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1523\/JNEUROSCI.4762-12.2013","volume":"33","author":"JD Dougherty","year":"2013","unstructured":"Dougherty JD, et al. The disruption of Celf6, a gene identified by translational profiling of serotonergic neurons, results in autism-related behaviors. J Neurosci. 2013;33(7):2732\u201353.","journal-title":"J Neurosci"},{"key":"2924_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2016.02.050","volume":"1647","author":"AE Brinegar","year":"2016","unstructured":"Brinegar AE, Cooper TA. Roles for RNA-binding proteins in development and disease. Brain Res. 2016;1647:1\u20138.","journal-title":"Brain Res"},{"issue":"17","key":"2924_CR61","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1093\/nar\/gkl620","volume":"34","author":"SD Auweter","year":"2006","unstructured":"Auweter SD, Oberstrass FC, Allain FH. Sequence-specific binding of single-stranded RNA: is there a code for recognition? Nucleic Acids Res. 2006;34(17):4943\u201359.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"2924_CR62","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1111\/j.1742-4658.2005.04653.x","volume":"272","author":"C Maris","year":"2005","unstructured":"Maris C, Dominguez C, Allain FH. The RNA recognition motif, a plastic RNA-binding platform to regulate post-transcriptional gene expression. FEBS J. 2005;272(9):2118\u201331.","journal-title":"FEBS J"},{"issue":"10","key":"2924_CR63","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.str.2010.09.006","volume":"18","author":"K Tripsianes","year":"2010","unstructured":"Tripsianes K, Sattler M. Repeat recognition. Structure. 2010;18(10):1228\u20139.","journal-title":"Structure"},{"issue":"12","key":"2924_CR64","doi-asserted-by":"publisher","first-page":"200328","DOI":"10.1098\/rsob.200328","volume":"10","author":"DSM Ottoz","year":"2020","unstructured":"Ottoz DSM, Berchowitz LE. The role of disorder in RNA binding affinity and specificity. Open Biol. 2020;10(12):200328.","journal-title":"Open Biol"},{"key":"2924_CR65","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Mart\u00ednez A, et al. An overview of alternative splicing defects implicated in Myotonic Dystrophy Type I. Genes (Basel). 2020;11(9):1109.","DOI":"10.3390\/genes11091109"},{"issue":"50","key":"2924_CR66","doi-asserted-by":"publisher","first-page":"47338","DOI":"10.1074\/jbc.M104911200","volume":"276","author":"S Anant","year":"2001","unstructured":"Anant S, et al. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor. J Biol Chem. 2001;276(50):47338\u201351.","journal-title":"J Biol Chem"},{"issue":"37","key":"2924_CR67","doi-asserted-by":"publisher","first-page":"28583","DOI":"10.1074\/jbc.M003083200","volume":"275","author":"PJ Good","year":"2000","unstructured":"Good PJ, et al. A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator. J Biol Chem. 2000;275(37):28583\u201392.","journal-title":"J Biol Chem"},{"issue":"1","key":"2924_CR68","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/hmg\/8.1.53","volume":"8","author":"X Lu","year":"1999","unstructured":"Lu X, Timchenko NA, Timchenko LT. Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy. Hum Mol Genet. 1999;8(1):53\u201360.","journal-title":"Hum Mol Genet"},{"issue":"22","key":"2924_CR69","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1093\/nar\/24.22.4407","volume":"24","author":"LT Timchenko","year":"1996","unstructured":"Timchenko LT, et al. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 1996;24(22):4407\u201314.","journal-title":"Nucleic Acids Res"},{"key":"2924_CR70","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1146\/annurev-neuro-062912-114322","volume":"36","author":"RB Darnell","year":"2013","unstructured":"Darnell RB. RNA protein interaction in neurons. Annu Rev Neurosci. 2013;36:243\u201370.","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"2924_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003337","volume":"9","author":"H Kuroyanagi","year":"2013","unstructured":"Kuroyanagi H, Watanabe Y, Hagiwara M. CELF family RNA-binding protein UNC-75 regulates two sets of mutually exclusive exons of the unc-32 gene in neuron-specific manners in Caenorhabditis elegans. PLoS Genet. 2013;9(2):e1003337.","journal-title":"PLoS Genet"},{"issue":"1","key":"2924_CR72","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12864-021-08217-6","volume":"23","author":"ME Ochs","year":"2022","unstructured":"Ochs ME, et al. Caenorhabditis elegans ETR-1\/CELF has broad effects on the muscle cell transcriptome, including genes that regulate translation and neuroblast migration. BMC Genomics. 2022;23(1):13.","journal-title":"BMC Genomics"},{"issue":"1","key":"2924_CR73","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.sbi.2012.11.006","volume":"23","author":"GM Daubner","year":"2013","unstructured":"Daubner GM, Cl\u00e9ry A, Allain FHT. RRM\u2013RNA recognition: NMR or crystallography\u2026and new findings. Curr Opin Struct Biol. 2013;23(1):100\u20138.","journal-title":"Curr Opin Struct Biol"},{"issue":"4","key":"2924_CR74","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.gde.2011.03.002","volume":"21","author":"I Vlasova-St Louis","year":"2011","unstructured":"Vlasova-St Louis I, Bohjanen PR. Coordinate regulation of mRNA decay networks by GU-rich elements and CELF1. Curr Opin Genet Dev. 2011;21(4):444\u201351.","journal-title":"Curr Opin Genet Dev"},{"issue":"3","key":"2924_CR75","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/jb\/mvm230","volume":"143","author":"D Mori","year":"2008","unstructured":"Mori D, et al. Quantitative analysis of CUG-BP1 binding to RNA repeats. J Biochem. 2008;143(3):377\u201383.","journal-title":"J Biochem"},{"issue":"1","key":"2924_CR76","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/emboj\/17.1.278","volume":"17","author":"L Paillard","year":"1998","unstructured":"Paillard L, et al. EDEN and EDEN-BP, a cis element and an associated factor that mediate sequence-specific mRNA deadenylation in Xenopus embryos. Embo J. 1998;17(1):278\u201387.","journal-title":"Embo J"},{"issue":"11\u201312","key":"2924_CR77","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1016\/j.yexcr.2008.04.018","volume":"314","author":"E Salisbury","year":"2008","unstructured":"Salisbury E, et al. Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG-binding protein, CUGBP1. Exp Cell Res. 2008;314(11\u201312):2266\u201378.","journal-title":"Exp Cell Res"},{"issue":"22","key":"2924_CR78","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.1093\/nar\/27.22.4517","volume":"27","author":"NA Timchenko","year":"1999","unstructured":"Timchenko NA, et al. CUG repeat binding protein (CUGBP1) interacts with the 5\u2019 region of C\/EBPbeta mRNA and regulates translation of C\/EBPbeta isoforms. Nucleic Acids Res. 1999;27(22):4517\u201325.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"2924_CR79","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1128\/MCB.00624-10","volume":"30","author":"B Rattenbacher","year":"2010","unstructured":"Rattenbacher B, et al. Analysis of CUGBP1 targets identifies GU-repeat sequences that mediate rapid mRNA decay. Mol Cell Biol. 2010;30(16):3970\u201380.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2924_CR80","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1016\/j.bbrc.2018.08.126","volume":"503","author":"K Belanger","year":"2018","unstructured":"Belanger K, et al. CELF1 contributes to aberrant alternative splicing patterns in the type 1 diabetic heart. Biochem Biophys Res Commun. 2018;503(4):3205\u201311.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"2924_CR81","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1261\/rna.049940.115","volume":"21","author":"PR Bohjanen","year":"2015","unstructured":"Bohjanen PR, et al. Altered CELF1 binding to target transcripts in malignant T cells. RNA. 2015;21(10):1757\u201369.","journal-title":"RNA"},{"issue":"5","key":"2924_CR82","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/s12265-022-10209-0","volume":"15","author":"XX Li","year":"2022","unstructured":"Li XX, et al. circCELF1 inhibits myocardial fibrosis by regulating the expression of DKK2 through FTO\/m(6)A and miR-636. J Cardiovasc Transl Res. 2022;15(5):998\u20131009.","journal-title":"J Cardiovasc Transl Res"},{"issue":"8","key":"2924_CR83","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/dvdy.24413","volume":"245","author":"Y Blech-Hermoni","year":"2016","unstructured":"Blech-Hermoni Y, et al. CUG-BP, elav-like family member 1 (CELF1) is required for normal myofibrillogenesis, morphogenesis, and contractile function in the embryonic heart. Dev Dyn. 2016;245(8):854\u201373.","journal-title":"Dev Dyn"},{"issue":"9","key":"2924_CR84","doi-asserted-by":"publisher","first-page":"18009","DOI":"10.3390\/ijms140918009","volume":"14","author":"N Tahara","year":"2013","unstructured":"Tahara N, Bessho Y, Matsui T. Celf1 is required for formation of endoderm-derived organs in zebrafish. Int J Mol Sci. 2013;14(9):18009\u201323.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2924_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083777","volume":"8","author":"R Cardani","year":"2013","unstructured":"Cardani R, et al. Overexpression of CUGBP1 in skeletal muscle from adult classic myotonic dystrophy type 1 but not from myotonic dystrophy type 2. PLoS ONE. 2013;8(12):e83777.","journal-title":"PLoS ONE"},{"issue":"1","key":"2924_CR86","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00441-021-03541-5","volume":"387","author":"X Hu","year":"2022","unstructured":"Hu X, et al. RNA-binding protein CELF1 promotes cardiac hypertrophy via interaction with PEBP1 in cardiomyocytes. Cell Tissue Res. 2022;387(1):111\u201321.","journal-title":"Cell Tissue Res"},{"issue":"6","key":"2924_CR87","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/15476286.2016.1176663","volume":"13","author":"S Ajith","year":"2016","unstructured":"Ajith S, et al. Position-dependent activity of CELF2 in the regulation of splicing and implications for signal-responsive regulation in T cells. RNA Biol. 2016;13(6):569\u201381.","journal-title":"RNA Biol"},{"issue":"20","key":"2924_CR88","doi-asserted-by":"publisher","first-page":"7273","DOI":"10.1093\/nar\/gkq573","volume":"38","author":"G Dujardin","year":"2010","unstructured":"Dujardin G, et al. CELF proteins regulate CFTR pre-mRNA splicing: essential role of the divergent domain of ETR-3. Nucleic Acids Res. 2010;38(20):7273\u201385.","journal-title":"Nucleic Acids Res"},{"issue":"19","key":"2924_CR89","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/s41388-024-03006-3","volume":"43","author":"T Guo","year":"2024","unstructured":"Guo T, et al. Loss of RNA-binding protein CELF2 promotes acute leukemia development via FAT10-mTORC1. Oncogene. 2024;43(19):1476\u201387.","journal-title":"Oncogene"},{"issue":"4","key":"2924_CR90","doi-asserted-by":"publisher","first-page":"G1025","DOI":"10.1152\/ajpgi.00602.2007","volume":"294","author":"D Subramaniam","year":"2008","unstructured":"Subramaniam D, et al. Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2. Am J Physiol Gastrointest Liver Physiol. 2008;294(4):G1025\u201332.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"11","key":"2924_CR91","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/hmg\/ddi162","volume":"14","author":"TH Ho","year":"2005","unstructured":"Ho TH, et al. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum Mol Genet. 2005;14(11):1539\u201347.","journal-title":"Hum Mol Genet"},{"key":"2924_CR92","doi-asserted-by":"crossref","unstructured":"Li X, et al. CELF2 promotes tau exon 10 inclusion via hinge domain-mediated nuclear condensation. bioRxiv, 2024.","DOI":"10.1101\/2024.11.02.621395"},{"issue":"10","key":"2924_CR93","doi-asserted-by":"publisher","first-page":"109226","DOI":"10.1016\/j.celrep.2021.109226","volume":"35","author":"MJ MacPherson","year":"2021","unstructured":"MacPherson MJ, et al. Nucleocytoplasmic transport of the RNA-binding protein CELF2 regulates neural stem cell fates. Cell Rep. 2021;35(10):109226.","journal-title":"Cell Rep"},{"issue":"15","key":"2924_CR94","doi-asserted-by":"publisher","first-page":"6491","DOI":"10.1021\/acs.jmedchem.7b01684","volume":"61","author":"L Zhang","year":"2018","unstructured":"Zhang L, et al. UNC-51-like kinase 1: From an autophagic initiator to multifunctional drug target. J Med Chem. 2018;61(15):6491\u2013500.","journal-title":"J Med Chem"},{"issue":"19","key":"2924_CR95","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1101\/gad.267245.115","volume":"29","author":"NM Martinez","year":"2015","unstructured":"Martinez NM, et al. Widespread JNK-dependent alternative splicing induces a positive feedback loop through CELF2-mediated regulation of MKK7 during T-cell activation. Genes Dev. 2015;29(19):2054\u201366.","journal-title":"Genes Dev"},{"issue":"8","key":"2924_CR96","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1101\/gr.220517.117","volume":"27","author":"MR Gazzara","year":"2017","unstructured":"Gazzara MR, et al. Ancient antagonism between CELF and RBFOX families tunes mRNA splicing outcomes. Genome Res. 2017;27(8):1360\u201370.","journal-title":"Genome Res"},{"key":"2924_CR97","doi-asserted-by":"crossref","unstructured":"Schultz AS, et al. Activation-Dependent TRAF3 Exon 8 Alternative Splicing Is Controlled by CELF2 and hnRNP C Binding to an Upstream Intronic Element. Mol Cell Biol. 2017;37(7):e00488\u201316.","DOI":"10.1128\/MCB.00488-16"},{"key":"2924_CR98","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.omtn.2020.10.011","volume":"23","author":"Q Guo","year":"2021","unstructured":"Guo Q, et al. The RNA-binding protein CELF2 inhibits ovarian cancer progression by stabilizing FAM198B. Mol Ther Nucleic Acids. 2021;23:169\u201384.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"2924_CR99","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/humu.24130","volume":"42","author":"T Itai","year":"2021","unstructured":"Itai T, et al. De novo variants in CELF2 that disrupt the nuclear localization signal cause developmental and epileptic encephalopathy. Hum Mutat. 2021;42(1):66\u201376.","journal-title":"Hum Mutat"},{"issue":"1","key":"2924_CR100","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s12035-024-04250-0","volume":"62","author":"X Duan","year":"2025","unstructured":"Duan X, et al. CELF2 deficiency demonstrates autism-like behaviors and interferes with late development of cortical neurons in mice. Mol Neurobiol. 2025;62(1):156\u201368.","journal-title":"Mol Neurobiol"},{"issue":"9","key":"2924_CR101","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/gtc.12169","volume":"19","author":"A Ishizuka","year":"2014","unstructured":"Ishizuka A, et al. Formation of nuclear bodies by the lncRNA Gomafu-associating proteins Celf3 and SF1. Genes Cells. 2014;19(9):704\u201321.","journal-title":"Genes Cells"},{"key":"2924_CR102","doi-asserted-by":"crossref","unstructured":"\u010co\u010dkov\u00e1 Z, et al. Protein profiling of SH-SY5Y neuroblastoma cells: the effect of rhein. J Biosci, 2019;44(4):88.","DOI":"10.1007\/s12038-019-9908-0"},{"key":"2924_CR103","doi-asserted-by":"crossref","unstructured":"Corsi A, et al. Tau isoforms: gaining insight into MAPT alternative splicing. Int J Mol Sci. 2022;23(23):15383.","DOI":"10.3390\/ijms232315383"},{"issue":"5","key":"2924_CR104","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1046\/j.1471-4159.2003.02232.x","volume":"88","author":"J Wang","year":"2004","unstructured":"Wang J, et al. Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of cis elements and trans factors. J Neurochem. 2004;88(5):1078\u201390.","journal-title":"J Neurochem"},{"issue":"2","key":"2924_CR105","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ydbio.2010.07.005","volume":"345","author":"LD Horb","year":"2010","unstructured":"Horb LD, Horb ME. BrunoL1 regulates endoderm proliferation through translational enhancement of cyclin A2 mRNA. Dev Biol. 2010;345(2):156\u201369.","journal-title":"Dev Biol"},{"issue":"24","key":"2924_CR106","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1002\/1873-3468.12486","volume":"590","author":"J Xu","year":"2016","unstructured":"Xu J, et al. A transcriptomic landscape of human papillomavirus 16 E6-regulated gene expression and splicing events. FEBS Lett. 2016;590(24):4594\u2013605.","journal-title":"FEBS Lett"},{"issue":"4","key":"2924_CR107","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1261\/rna.2191903","volume":"9","author":"N Gromak","year":"2003","unstructured":"Gromak N, et al. Antagonistic regulation of alpha-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein. RNA. 2003;9(4):443\u201356.","journal-title":"RNA"},{"issue":"19","key":"2924_CR108","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.1093\/nar\/gkp681","volume":"37","author":"Y Kino","year":"2009","unstructured":"Kino Y, et al. MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1. Nucleic Acids Res. 2009;37(19):6477\u201390.","journal-title":"Nucleic Acids Res"},{"key":"2924_CR109","doi-asserted-by":"publisher","first-page":"100184","DOI":"10.1016\/j.ynpai.2025.100184","volume":"18","author":"MG Mueth","year":"2025","unstructured":"Mueth MG, et al. The RNA-binding protein CELF4 is a negative regulator of sensory neuron excitability and mechanical and heat behavioral sensitivity. Neurobiology of Pain. 2025;18:100184.","journal-title":"Neurobiology of Pain"},{"issue":"7","key":"2924_CR110","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1601-183X.2011.00717.x","volume":"10","author":"JL Wagnon","year":"2011","unstructured":"Wagnon JL, et al. Etiology of a genetically complex seizure disorder in Celf4 mutant mice. Genes Brain Behav. 2011;10(7):765\u201377.","journal-title":"Genes Brain Behav"},{"key":"2924_CR111","doi-asserted-by":"crossref","unstructured":"Brimacombe KR, Ladd AN, Cloning and embryonic expression patterns of the chicken CELF family. Dev Dynamics. 2007;236(8):spc1\u2013fvii, 2027\u20132367.","DOI":"10.1002\/dvdy.21209"},{"issue":"4","key":"2924_CR112","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4161\/rna.7056","volume":"5","author":"IA Vlasova","year":"2008","unstructured":"Vlasova IA, Bohjanen PR. Posttranscriptional regulation of gene networks by GU-rich elements and CELF proteins. RNA Biol. 2008;5(4):201\u20137.","journal-title":"RNA Biol"},{"issue":"3","key":"2924_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006680","volume":"13","author":"RA Kline","year":"2017","unstructured":"Kline RA, et al. Comparison of independent screens on differentially vulnerable motor neurons reveals alpha-synuclein as a common modifier in motor neuron diseases. PLoS Genet. 2017;13(3):e1006680.","journal-title":"PLoS Genet"},{"issue":"15","key":"2924_CR114","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/S0960-9822(03)00532-3","volume":"13","author":"PM Loria","year":"2003","unstructured":"Loria PM, et al. Two neuronal, nuclear-localized RNA binding proteins involved in synaptic transmission. Curr Biol. 2003;13(15):1317\u201323.","journal-title":"Curr Biol"},{"issue":"3","key":"2924_CR115","first-page":"4657","volume":"17","author":"F Zou","year":"2018","unstructured":"Zou F, et al. Human cytomegalovirus UL141 protein interacts with CELF5 and affects viral DNA replication. Mol Med Rep. 2018;17(3):4657\u201364.","journal-title":"Mol Med Rep"},{"issue":"12","key":"2924_CR116","doi-asserted-by":"publisher","first-page":"108531","DOI":"10.1016\/j.celrep.2020.108531","volume":"33","author":"MA Rieger","year":"2020","unstructured":"Rieger MA, et al. CLIP and Massively Parallel Functional Analysis of CELF6 Reveal a Role in Destabilizing Synaptic Gene mRNAs through Interaction with 3\u2019 UTR Elements. Cell Rep. 2020;33(12):108531.","journal-title":"Cell Rep"},{"issue":"1","key":"2924_CR117","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0169-5002(03)00146-6","volume":"41","author":"J-Y Han","year":"2003","unstructured":"Han J-Y, et al. Immunohistochemical expression of integrins and extracellular matrix proteins in non-small cell lung cancer: correlation with lymph node metastasis. Lung Cancer. 2003;41(1):65\u201370.","journal-title":"Lung Cancer"},{"issue":"6","key":"2924_CR118","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3233\/CBM-140424","volume":"14","author":"R Roudi","year":"2014","unstructured":"Roudi R, et al. Clinical significance of putative cancer stem cell marker CD44 in different histological subtypes of lung cancer. Cancer Biomark. 2014;14(6):457\u201367.","journal-title":"Cancer Biomark"},{"key":"2924_CR119","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.13800","volume":"10","author":"H Ma","year":"2022","unstructured":"Ma H, et al. RNA-binding protein CELF6 modulates transcription and splicing levels of genes associated with tumorigenesis in lung cancer A549 cells. PeerJ. 2022;10:e13800.","journal-title":"PeerJ"},{"issue":"1","key":"2924_CR120","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10549-020-05753-9","volume":"183","author":"X Yang","year":"2020","unstructured":"Yang X, et al. CELF6 modulates triple-negative breast cancer progression by regulating the stability of FBP1 mRNA. Breast Cancer Res Treat. 2020;183(1):71\u201382.","journal-title":"Breast Cancer Res Treat"},{"key":"2924_CR121","doi-asserted-by":"crossref","unstructured":"Fu Z, et al. CELF6 as an oncogene in colorectal cancer: targeting stem-cell-like properties through modulation of HOXA5 mRNA stability. FBL. 2024; 29(11):395.","DOI":"10.31083\/j.fbl2911395"},{"issue":"10","key":"2924_CR122","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41419-019-1927-0","volume":"10","author":"G Liu","year":"2019","unstructured":"Liu G, et al. RNA-binding protein CELF6 is cell cycle regulated and controls cancer cell proliferation by stabilizing p21. Cell Death Dis. 2019;10(10):688.","journal-title":"Cell Death Dis"},{"issue":"14","key":"2924_CR123","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1042\/CS20191174","volume":"134","author":"H Wang","year":"2020","unstructured":"Wang H, et al. RNA-binding protein CELF1 enhances cell migration, invasion, and chemoresistance by targeting ETS2 in colorectal cancer. Clin Sci (Lond). 2020;134(14):1973\u201390.","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"2924_CR124","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.7150\/ijbs.11344","volume":"11","author":"L Xia","year":"2015","unstructured":"Xia L, et al. CELF1 is up-regulated in glioma and promotes glioma cell proliferation by suppression of CDKN1B. Int J Biol Sci. 2015;11(11):1314\u201324.","journal-title":"Int J Biol Sci"},{"key":"2924_CR125","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fmolb.2019.00065","volume":"6","author":"JM Garc\u00eda-C\u00e1rdenas","year":"2019","unstructured":"Garc\u00eda-C\u00e1rdenas JM, et al. Post-transcriptional Regulation of Colorectal Cancer: A Focus on RNA-Binding Proteins. Front Mol Biosci. 2019;6:65.","journal-title":"Front Mol Biosci"},{"issue":"3","key":"2924_CR126","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/carcin\/bgz113","volume":"41","author":"YT Yeung","year":"2019","unstructured":"Yeung YT, et al. CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction. Carcinogenesis. 2019;41(3):377\u201389.","journal-title":"Carcinogenesis"},{"issue":"7","key":"2924_CR127","first-page":"547","volume":"21","author":"Z Liu","year":"2024","unstructured":"Liu Z, Zhou X, Tang F. Epigenetic regulators as the foundation for molecular classification of colorectal cancer. Cancer Biol Med. 2024;21(7):547\u201352.","journal-title":"Cancer Biol Med"},{"key":"2924_CR128","doi-asserted-by":"publisher","first-page":"goac035","DOI":"10.1093\/gastro\/goac035","volume":"10","author":"S Parmar","year":"2022","unstructured":"Parmar S, Easwaran H. Genetic and epigenetic dependencies in colorectal cancer development. Gastroenterol Rep (Oxf). 2022;10:goac035.","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"41","key":"2924_CR129","doi-asserted-by":"publisher","first-page":"43620","DOI":"10.18632\/oncotarget.6204","volume":"6","author":"RP House","year":"2015","unstructured":"House RP, et al. RNA-binding protein CELF1 promotes tumor growth and alters gene expression in oral squamous cell carcinoma. Oncotarget. 2015;6(41):43620\u201334.","journal-title":"Oncotarget"},{"issue":"1","key":"2924_CR130","first-page":"1","volume":"22","author":"D Li","year":"2025","unstructured":"Li D, et al. The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignancies. RNA Biol. 2025;22(1):1\u201314.","journal-title":"RNA Biol"},{"issue":"20","key":"2924_CR131","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.3390\/cancers16203502","volume":"16","author":"V Singh","year":"2024","unstructured":"Singh V, et al. RNA binding proteins as potential therapeutic targets in colorectal cancer. Cancers. 2024;16(20):3502.","journal-title":"Cancers"},{"issue":"2","key":"2924_CR132","first-page":"68","volume":"6","author":"S Anant","year":"2010","unstructured":"Anant S, et al. Role of RNA-binding proteins in colorectal carcinogenesis. Curr Colorectal Cancer Rep. 2010;6(2):68\u201373.","journal-title":"Curr Colorectal Cancer Rep"},{"issue":"7","key":"2924_CR133","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.21037\/tcr-21-311","volume":"10","author":"ZP Qi","year":"2021","unstructured":"Qi ZP, et al. RNA binding protein CUGBP1 mediates the liver metastasis of colorectal cancer by regulating the ErbB signal pathway. Transl Cancer Res. 2021;10(7):3373\u201388.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"2924_CR134","doi-asserted-by":"publisher","first-page":"27","DOI":"10.7178\/ig.1.1.7","volume":"1","author":"S Ramalingam","year":"2012","unstructured":"Ramalingam S, et al. Reduced expression of RNA binding protein CELF2, a putative tumor suppressor gene in colon cancer. Immunogastroenterology. 2012;1(1):27\u201333.","journal-title":"Immunogastroenterology"},{"issue":"7","key":"2924_CR135","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41419-023-05924-8","volume":"14","author":"B Liu","year":"2023","unstructured":"Liu B, et al. Long noncoding RNA LINC01594 inhibits the CELF6-mediated splicing of oncogenic CD44 variants to promote colorectal cancer metastasis. Cell Death Dis. 2023;14(7):427.","journal-title":"Cell Death Dis"},{"issue":"11","key":"2924_CR136","doi-asserted-by":"publisher","first-page":"395","DOI":"10.31083\/j.fbl2911395","volume":"29","author":"Z Fu","year":"2024","unstructured":"Fu Z, et al. CELF6 as an oncogene in colorectal cancer: targeting stem-cell-like properties through modulation of HOXA5 mRNA stability. Front Biosci (Landmark Ed). 2024;29(11):395.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"12","key":"2924_CR137","doi-asserted-by":"publisher","first-page":"9730","DOI":"10.1002\/jcb.27290","volume":"119","author":"B Zhou","year":"2018","unstructured":"Zhou B, Guo R. Integrative analysis of significant RNA-binding proteins in colorectal cancer metastasis. J Cell Biochem. 2018;119(12):9730\u201341.","journal-title":"J Cell Biochem"},{"key":"2924_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2021.101941","volume":"72","author":"CC Teerlink","year":"2021","unstructured":"Teerlink CC, et al. An intronic variant in the CELF4 gene is associated with risk for colorectal cancer. Cancer Epidemiol. 2021;72:101941.","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"2924_CR139","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1091\/mbc.e11-05-0456","volume":"23","author":"YH Cui","year":"2012","unstructured":"Cui YH, et al. miR-503 represses CUG-binding protein 1 translation by recruiting CUGBP1 mRNA to processing bodies. Mol Biol Cell. 2012;23(1):151\u201362.","journal-title":"Mol Biol Cell"},{"issue":"10","key":"2924_CR140","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1091\/mbc.E14-11-1500","volume":"26","author":"L Liu","year":"2015","unstructured":"Liu L, et al. Competition between RNA-binding proteins CELF1 and HuR modulates MYC translation and intestinal epithelium renewal. Mol Biol Cell. 2015;26(10):1797\u2013810.","journal-title":"Mol Biol Cell"},{"issue":"5","key":"2924_CR141","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.molmed.2018.03.008","volume":"24","author":"P Chatterji","year":"2018","unstructured":"Chatterji P, Rustgi AK. RNA binding proteins in intestinal epithelial biology and colorectal cancer. Trends Mol Med. 2018;24(5):490\u2013506.","journal-title":"Trends Mol Med"},{"issue":"8","key":"2924_CR142","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/mc.23023","volume":"58","author":"J New","year":"2019","unstructured":"New J, et al. Pleotropic role of RNA binding protein CELF2 in autophagy induction. Mol Carcinog. 2019;58(8):1400\u20139.","journal-title":"Mol Carcinog"},{"key":"2924_CR143","doi-asserted-by":"publisher","first-page":"A369","DOI":"10.1136\/esmoopen-2018-EACR25.870","volume":"3","author":"L Gallego-Paez","year":"2018","unstructured":"Gallego-Paez L, Martins M, Barbosa-Morais N. PO-358 CELf2 at the core of a prognostic alternative splicing signature in colorectal cancer. ESMO Open. 2018;3:A369.","journal-title":"ESMO Open"},{"issue":"5","key":"2924_CR144","doi-asserted-by":"publisher","first-page":"G1235","DOI":"10.1152\/ajpgi.00037.2008","volume":"294","author":"G Natarajan","year":"2008","unstructured":"Natarajan G, et al. CUGBP2 downregulation by prostaglandin E2 protects colon cancer cells from radiation-induced mitotic catastrophe. Am J Physiol Gastrointest Liver Physiol. 2008;294(5):G1235\u201344.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"2924_CR145","doi-asserted-by":"publisher","first-page":"G971","DOI":"10.1152\/ajpgi.00540.2007","volume":"294","author":"S Ramalingam","year":"2008","unstructured":"Ramalingam S, et al. Novel intestinal splice variants of RNA-binding protein CUGBP2: isoform-specific effects on mitotic catastrophe. Am J Physiol Gastrointest Liver Physiol. 2008;294(4):G971\u201381.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"33","key":"2924_CR146","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.1038\/onc.2008.97","volume":"27","author":"SM Sureban","year":"2008","unstructured":"Sureban SM, et al. Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe. Oncogene. 2008;27(33):4544\u201356.","journal-title":"Oncogene"},{"key":"2924_CR147","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.biopha.2018.02.104","volume":"101","author":"J Wang","year":"2018","unstructured":"Wang J, et al. miR-615-3p promotes proliferation and migration and inhibits apoptosis through its potential target CELF2 in gastric cancer. Biomed Pharmacother. 2018;101:406\u201313.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"2924_CR148","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3892\/ijo.2015.3080","volume":"47","author":"B Fan","year":"2015","unstructured":"Fan B, et al. Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2. Int J Oncol. 2015;47(3):1025\u201333.","journal-title":"Int J Oncol"},{"issue":"17","key":"2924_CR149","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1177\/15353702211011576","volume":"246","author":"L Ge","year":"2021","unstructured":"Ge L, et al. Hypoxic colorectal cancer-secreted exosomes deliver miR-210-3p to normoxic tumor cells to elicit a protumoral effect. Exp Biol Med (Maywood). 2021;246(17):1895\u2013906.","journal-title":"Exp Biol Med (Maywood)"},{"key":"2924_CR150","doi-asserted-by":"publisher","DOI":"10.1177\/15330338211019504","volume":"20","author":"T Li","year":"2021","unstructured":"Li T, et al. RNA binding protein-based model for prognostic prediction of colorectal cancer. Technol Cancer Res Treat. 2021;20:15330338211019504.","journal-title":"Technol Cancer Res Treat"},{"key":"2924_CR151","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.11219","volume":"9","author":"Y Miao","year":"2021","unstructured":"Miao Y, et al. Construction and validation of an RNA-binding protein-associated prognostic model for colorectal cancer. PeerJ. 2021;9:e11219.","journal-title":"PeerJ"},{"issue":"1","key":"2924_CR152","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12957-020-01995-5","volume":"18","author":"X Fan","year":"2020","unstructured":"Fan X, et al. Integrated analysis of RNA-binding proteins in human colorectal cancer. World J Surg Oncol. 2020;18(1):222.","journal-title":"World J Surg Oncol"},{"key":"2924_CR153","unstructured":"Zarogoulidis K, et al. Treatment of non-small cell lung cancer (NSCLC). J Thorac Dis. 2013;5 Suppl 4(Suppl 4):S389\u201396."},{"issue":"10374","key":"2924_CR154","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0140-6736(22)01694-4","volume":"401","author":"SJ Adams","year":"2023","unstructured":"Adams SJ, et al. Lung cancer screening. Lancet. 2023;401(10374):390\u2013408.","journal-title":"Lancet"},{"key":"2924_CR155","doi-asserted-by":"publisher","first-page":"1275957","DOI":"10.3389\/fimmu.2023.1275957","volume":"14","author":"J Zeng","year":"2023","unstructured":"Zeng J, et al. Histological transformation into SCLC: An important resistance mechanism of NSCLC upon immunotherapy. Front Immunol. 2023;14:1275957.","journal-title":"Front Immunol"},{"issue":"1","key":"2924_CR156","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s12672-025-02413-6","volume":"16","author":"X Lei","year":"2025","unstructured":"Lei X, Zheng Y, Su W. RNA-binding proteins and autophagy in lung cancer: mechanistic insights and therapeutic perspectives. Discov Oncol. 2025;16(1):599.","journal-title":"Discov Oncol"},{"issue":"22","key":"2924_CR157","doi-asserted-by":"publisher","first-page":"24560","DOI":"10.18632\/aging.203576","volume":"13","author":"W Ge","year":"2021","unstructured":"Ge W, et al. Circular RNA CELF1 drives immunosuppression and anti-PD1 therapy resistance in non-small cell lung cancer via the miR-491-5p\/EGFR axis. Aging (Albany NY). 2021;13(22):24560\u201379.","journal-title":"Aging (Albany NY)"},{"issue":"10","key":"2924_CR158","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s12094-013-1005-5","volume":"15","author":"W Jiao","year":"2013","unstructured":"Jiao W, et al. CUG-binding protein 1 (CUGBP1) expression and prognosis of non-small cell lung cancer. Clin Transl Oncol. 2013;15(10):789\u201395.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"2924_CR159","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1615\/CritRevEukaryotGeneExpr.2022043174","volume":"33","author":"Y Yang","year":"2022","unstructured":"Yang Y, et al. Natural Antisense Long Noncoding RNA HHIP-AS1 Suppresses Non-Small-Cell Lung Cancer Progression by Increasing HHIP Stability via Interaction with CELF2. Crit Rev Eukaryot Gene Expr. 2022;33(1):67\u201377.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"11","key":"2924_CR160","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12032-022-01752-6","volume":"39","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Wang Y. MiR-210-3p targets CELF2 to facilitate progression of lung squamous carcinoma through PI3K\/AKT pathway. Med Oncol. 2022;39(11):161.","journal-title":"Med Oncol"},{"issue":"6","key":"2924_CR161","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1007\/s13277-015-3103-1","volume":"36","author":"C Gao","year":"2015","unstructured":"Gao C, et al. Overexpression of CUGBP1 is associated with the progression of non-small cell lung cancer. Tumour Biol. 2015;36(6):4583\u20139.","journal-title":"Tumour Biol"},{"issue":"2","key":"2924_CR162","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10528-022-10285-6","volume":"61","author":"J Wang","year":"2023","unstructured":"Wang J, Lai X, Peng X. CircLIFR inhibits non-small cell lung cancer progression by acting as a miR-429 sponge to enhance CELF2 expression. Biochem Genet. 2023;61(2):725\u201341.","journal-title":"Biochem Genet"},{"issue":"9","key":"2924_CR163","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/ncpneuro0289","volume":"2","author":"JA Schwartzbaum","year":"2006","unstructured":"Schwartzbaum JA, et al. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol. 2006;2(9):494\u2013503 (quiz 1 p following 516).","journal-title":"Nat Clin Pract Neurol"},{"issue":"1","key":"2924_CR164","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13059-021-02259-5","volume":"22","author":"L Wang","year":"2021","unstructured":"Wang L, et al. The evolution of alternative splicing in glioblastoma under therapy. Genome Biol. 2021;22(1):48.","journal-title":"Genome Biol"},{"key":"2924_CR165","doi-asserted-by":"crossref","unstructured":"Wang Z, et al. Integrated analysis of RNA-binding proteins in glioma. Cancers (Basel). 2020;12(4):892.","DOI":"10.3390\/cancers12040892"},{"issue":"11","key":"2924_CR166","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1093\/brain\/awaa273","volume":"143","author":"AC Fuentes-Fayos","year":"2020","unstructured":"Fuentes-Fayos AC, et al. Splicing machinery dysregulation drives glioblastoma development\/aggressiveness: oncogenic role of SRSF3. Brain. 2020;143(11):3273\u201393.","journal-title":"Brain"},{"issue":"20","key":"2924_CR167","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.3390\/cancers15205038","volume":"15","author":"L Turchi","year":"2023","unstructured":"Turchi L, et al. CELF2 sustains a proliferating\/OLIG2+ glioblastoma cell phenotype via the epigenetic repression of SOX3. Cancers. 2023;15(20):5038.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"2924_CR168","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1111\/jcmm.14976","volume":"24","author":"YB Pan","year":"2020","unstructured":"Pan YB, et al. Transcriptome analyses reveal molecular mechanisms underlying phenotypic differences among transcriptional subtypes of glioblastoma. J Cell Mol Med. 2020;24(7):3901\u201316.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2924_CR169","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41467-022-28253-4","volume":"13","author":"R Siddaway","year":"2022","unstructured":"Siddaway R, et al. Splicing is an alternate oncogenic pathway activation mechanism in glioma. Nat Commun. 2022;13(1):588.","journal-title":"Nat Commun"},{"issue":"5","key":"2924_CR170","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.5114\/aoms.2020.95027","volume":"16","author":"H Wang","year":"2020","unstructured":"Wang H, et al. MiR-330-3p functions as a tumor suppressor that regulates glioma cell proliferation and migration by targeting CELF1. Arch Med Sci. 2020;16(5):1166\u201375.","journal-title":"Arch Med Sci"},{"issue":"22","key":"2924_CR171","doi-asserted-by":"publisher","first-page":"10418","DOI":"10.1111\/jcmm.16970","volume":"25","author":"B Fan","year":"2021","unstructured":"Fan B, et al. miR-363-3p induces EMT via the Wnt\/\u03b2-catenin pathway in glioma cells by targeting CELF2. J Cell Mol Med. 2021;25(22):10418\u201329.","journal-title":"J Cell Mol Med"},{"issue":"17","key":"2924_CR172","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.3390\/cancers13174287","volume":"13","author":"S \u0141ukasiewicz","year":"2021","unstructured":"\u0141ukasiewicz S, et al. Breast cancer\u2014epidemiology, risk factors, classification, prognostic markers, and current treatment strategies\u2014an updated review. Cancers. 2021;13(17):4287.","journal-title":"Cancers"},{"issue":"1","key":"2924_CR173","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/PPO.0000000000000500","volume":"27","author":"FM Howard","year":"2021","unstructured":"Howard FM, Olopade OI. Epidemiology of triple-negative breast cancer: a review. Cancer J. 2021;27(1):8\u201316.","journal-title":"Cancer J"},{"issue":"11","key":"2924_CR174","doi-asserted-by":"publisher","first-page":"107826","DOI":"10.1016\/j.jbc.2024.107826","volume":"300","author":"S Massey","year":"2024","unstructured":"Massey S, et al. PKC-mediated phosphorylation governs the stability and function of CELF1 as a driver of EMT in breast epithelial cells. J Biol Chem. 2024;300(11):107826.","journal-title":"J Biol Chem"},{"issue":"3","key":"2924_CR175","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"2924_CR176","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3892\/etm.2021.10330","volume":"22","author":"L Zhou","year":"2021","unstructured":"Zhou L, Xie X. RNA-binding protein CELF2 inhibits breast cancer cell invasion and angiogenesis by downregulating NFATc1. Exp Ther Med. 2021;22(2):898.","journal-title":"Exp Ther Med"},{"issue":"9","key":"2924_CR177","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","volume":"2","author":"Y Xia","year":"2014","unstructured":"Xia Y, Shen S, Verma IM. NF-\u03baB, an active player in human cancers. Cancer Immunol Res. 2014;2(9):823\u201330.","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"2924_CR178","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.bbrc.2017.07.164","volume":"491","author":"K Zhu","year":"2017","unstructured":"Zhu K, et al. Hairless controls hair fate decision via Wnt\/\u03b2-catenin signaling. Biochem Biophys Res Commun. 2017;491(3):567\u201370.","journal-title":"Biochem Biophys Res Commun"},{"key":"2924_CR179","doi-asserted-by":"crossref","unstructured":"Shen Y, et al. The histone demethylase HR suppresses breast cancer development through enhanced CELF2 tumor suppressor activity. Cancers (Basel). 2022;14(19):4648.","DOI":"10.3390\/cancers14194648"},{"issue":"1","key":"2924_CR180","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13148-016-0198-1","volume":"8","author":"F Zehentmayr","year":"2016","unstructured":"Zehentmayr F, et al. Hsa-miR-375 is a predictor of local control in early stage breast cancer. Clin Epigenetics. 2016;8(1):28.","journal-title":"Clin Epigenetics"},{"key":"2924_CR181","doi-asserted-by":"publisher","first-page":"E1404","DOI":"10.3390\/genes11121404","volume":"11","author":"B Zellinger","year":"2020","unstructured":"Zellinger B, et al. Hsa-miR-375\/RASD1 signaling may predict local control in early breast cancer. Genes. 2020;11:E1404. https:\/\/doi.org\/10.3390\/genes11121404.","journal-title":"Genes"},{"issue":"1","key":"2924_CR182","doi-asserted-by":"publisher","first-page":"152754","DOI":"10.1016\/j.prp.2019.152754","volume":"216","author":"W Tang","year":"2020","unstructured":"Tang W, et al. The role of upregulated miR-375 expression in breast cancer: an in vitro and in silico study. Pathol Res Pract. 2020;216(1):152754.","journal-title":"Pathol Res Pract"},{"issue":"11","key":"2924_CR183","doi-asserted-by":"publisher","first-page":"e48692","DOI":"10.1371\/journal.pone.0048692","volume":"7","author":"K Jonsdottir","year":"2012","unstructured":"Jonsdottir K, et al. Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers. PLoS ONE. 2012;7(11):e48692.","journal-title":"PLoS ONE"},{"key":"2924_CR184","doi-asserted-by":"publisher","first-page":"1468488","DOI":"10.3389\/fonc.2024.1468488","volume":"14","author":"T Zhang","year":"2024","unstructured":"Zhang T, Zhang Y, Leng X. Global, regional, and national trends in gastric cancer burden: 1990-2021 and projections to 2040. Front Oncol. 2024;14:1468488.","journal-title":"Front Oncol"},{"issue":"12","key":"2924_CR185","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3748\/wjg.v28.i12.1187","volume":"28","author":"M Ilic","year":"2022","unstructured":"Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol. 2022;28(12):1187\u2013203.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"2924_CR186","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s12010-014-0937-8","volume":"173","author":"X Wang","year":"2014","unstructured":"Wang X, et al. Lentivirus-mediated knockdown of CUGBP1 suppresses gastric cancer cell proliferation in vitro. Appl Biochem Biotechnol. 2014;173(6):1529\u201336.","journal-title":"Appl Biochem Biotechnol"},{"key":"2924_CR187","doi-asserted-by":"publisher","first-page":"153615","DOI":"10.1016\/j.prp.2021.153615","volume":"227","author":"HN Fan","year":"2021","unstructured":"Fan HN, et al. CircPTK2 inhibits the tumorigenesis and metastasis of gastric cancer by sponging miR-134-5p and activating CELF2\/PTEN signaling. Pathol Res Pract. 2021;227:153615.","journal-title":"Pathol Res Pract"},{"issue":"21","key":"2924_CR188","doi-asserted-by":"publisher","first-page":"21923","DOI":"10.18632\/aging.104013","volume":"12","author":"S Zhang","year":"2020","unstructured":"Zhang S, et al. Prognostic significance of survival-associated alternative splicing events in gastric cancer. Aging (Albany NY). 2020;12(21):21923\u201341.","journal-title":"Aging (Albany NY)"},{"key":"2924_CR189","doi-asserted-by":"crossref","unstructured":"Tan t, et al. Comprehensive analysis of the relevance of the CELF gene family to prognosis and immune infiltration in brain glioma. 2022.","DOI":"10.21203\/rs.3.rs-2304491\/v1"},{"issue":"6","key":"2924_CR190","doi-asserted-by":"publisher","first-page":"468","DOI":"10.18632\/oncoscience.62","volume":"1","author":"J Zhao","year":"2014","unstructured":"Zhao J, et al. Helicobacter pylori-induced STAT3 activation and signalling network in gastric cancer. Oncoscience. 2014;1(6):468\u201375.","journal-title":"Oncoscience"},{"issue":"4","key":"2924_CR191","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.ajpath.2014.11.029","volume":"185","author":"P Duconseil","year":"2015","unstructured":"Duconseil P, et al. Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma. Am J Pathol. 2015;185(4):1022\u201332.","journal-title":"Am J Pathol"},{"issue":"7","key":"2924_CR192","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1158\/1078-0432.CCR-18-1955","volume":"25","author":"V Bernard","year":"2019","unstructured":"Bernard V, et al. Single-cell transcriptomics of pancreatic cancer precursors demonstrates epithelial and microenvironmental heterogeneity as an early event in neoplastic progression. Clin Cancer Res. 2019;25(7):2194\u2013205.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2924_CR193","first-page":"2524","volume":"18","author":"E Alors-P\u00e9rez","year":"2024","unstructured":"Alors-P\u00e9rez E, et al. Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets. Mol Oncol. 2024;18(10):2524\u201340.","journal-title":"Mol Oncol"},{"issue":"11","key":"2924_CR194","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.3390\/ijms21114190","volume":"21","author":"M Gla\u00df","year":"2020","unstructured":"Gla\u00df M, Michl P, H\u00fcttelmaier S. RNA binding proteins as drivers and therapeutic target candidates in pancreatic ductal adenocarcinoma. Int J Mol Sci. 2020;21(11):4190.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2924_CR195","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/1878-0261.12847","volume":"15","author":"V Panzeri","year":"2021","unstructured":"Panzeri V, et al. The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma. Mol Oncol. 2021;15(2):579\u201395.","journal-title":"Mol Oncol"},{"issue":"1","key":"2924_CR196","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00423-015-1364-1","volume":"401","author":"A Jakstaite","year":"2016","unstructured":"Jakstaite A, et al. Upregulation of cugbp2 increases response of pancreatic cancer cells to chemotherapy. Langenbecks Arch Surg. 2016;401(1):99\u2013111.","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"2924_CR197","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016958","volume":"6","author":"D Subramaniam","year":"2011","unstructured":"Subramaniam D, et al. RNA binding protein CUGBP2\/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells. PLoS ONE. 2011;6(2):e16958.","journal-title":"PLoS ONE"},{"issue":"2","key":"2924_CR198","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4161\/rna.23315","volume":"10","author":"S Talwar","year":"2013","unstructured":"Talwar S, et al. Overexpression of RNA-binding protein CELF1 prevents apoptosis and destabilizes pro-apoptotic mRNAs in oral cancer cells. RNA Biol. 2013;10(2):277\u201386.","journal-title":"RNA Biol"},{"key":"2924_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101807","volume":"38","author":"Z Ye","year":"2021","unstructured":"Ye Z, et al. FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. Redox Biol. 2021;38:101807.","journal-title":"Redox Biol"},{"key":"2924_CR200","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.canlet.2016.12.014","volume":"388","author":"C Liang","year":"2017","unstructured":"Liang C, et al. ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer. Cancer Lett. 2017;388:303\u201311.","journal-title":"Cancer Lett"},{"key":"2924_CR201","doi-asserted-by":"crossref","unstructured":"Zhu H, et al. CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression. Int J Mol Sci. 2022;l23(20):12061.","DOI":"10.3390\/ijms232012061"},{"issue":"4","key":"2924_CR202","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1007\/s13277-015-4245-x","volume":"37","author":"W Xu","year":"2016","unstructured":"Xu W, et al. NFATC1 promotes cell growth and tumorigenesis in ovarian cancer up-regulating c-Myc through ERK1\/2\/p38 MAPK signal pathway. Tumour Biol. 2016;37(4):4493\u2013500.","journal-title":"Tumour Biol"},{"issue":"15","key":"2924_CR203","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1038\/sj.emboj.7601246","volume":"25","author":"M Buchholz","year":"2006","unstructured":"Buchholz M, et al. Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+\/calcineurin signaling pathway. EMBO J. 2006;25(15):3714\u201324.","journal-title":"EMBO J"},{"issue":"1","key":"2924_CR204","first-page":"1","volume":"110","author":"E Alors-P\u00e9rez","year":"2020","unstructured":"Alors-P\u00e9rez E, et al. The splicing factor CELF4 is dysregulated in neuroendocrine tumors, where it can enhance aggressiveness features. Neuroendocrinology. 2020;110(1):1\u2013312.","journal-title":"Neuroendocrinology"},{"issue":"3","key":"2924_CR205","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/MPA.0000000000000097","volume":"43","author":"SH Lee","year":"2014","unstructured":"Lee SH, et al. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival. Pancreas. 2014;43(3):380\u20138.","journal-title":"Pancreas"},{"issue":"25","key":"2924_CR206","doi-asserted-by":"publisher","first-page":"6252","DOI":"10.7150\/jca.35443","volume":"10","author":"F Liu","year":"2019","unstructured":"Liu F, et al. High expression of PDE4D correlates with poor prognosis and clinical progression in pancreaticductal adenocarcinoma. J Cancer. 2019;10(25):6252\u201360.","journal-title":"J Cancer"},{"key":"2924_CR207","doi-asserted-by":"publisher","first-page":"1115660","DOI":"10.3389\/fgene.2023.1115660","volume":"14","author":"K Guo","year":"2023","unstructured":"Guo K, et al. Exploring the key genetic association between chronic pancreatitis and pancreatic ductal adenocarcinoma through integrated bioinformatics. Front Genet. 2023;14:1115660.","journal-title":"Front Genet"},{"issue":"13","key":"2924_CR208","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1158\/0008-5472.CAN-20-2496","volume":"81","author":"G Sharbeen","year":"2021","unstructured":"Sharbeen G, et al. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 inhibition. Cancer Res. 2021;81(13):3461\u201379.","journal-title":"Cancer Res"},{"issue":"11","key":"2924_CR209","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1111\/cas.15547","volume":"113","author":"XX Zhu","year":"2022","unstructured":"Zhu XX, et al. Pancreatic ductal adenocarcinoma cells regulated the gemcitabine-resistance function of CAFs by LINC00460. Cancer Sci. 2022;113(11):3735\u201350.","journal-title":"Cancer Sci"},{"issue":"1","key":"2924_CR210","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-024-02062-3","volume":"23","author":"DZ Guo","year":"2024","unstructured":"Guo DZ, et al. Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts. Mol Cancer. 2024;23(1):157.","journal-title":"Mol Cancer"},{"key":"2924_CR211","doi-asserted-by":"publisher","first-page":"1285370","DOI":"10.3389\/fimmu.2023.1285370","volume":"14","author":"J Liu","year":"2023","unstructured":"Liu J, et al. Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma. Front Immunol. 2023;14:1285370.","journal-title":"Front Immunol"},{"issue":"1","key":"2924_CR212","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.25011\/cim.v37i1.20864","volume":"37","author":"Y Liu","year":"2014","unstructured":"Liu Y, et al. Suppression of CUGBP1 inhibits growth of hepatocellular carcinoma cells. Clin Invest Med. 2014;37(1):E10\u20138.","journal-title":"Clin Invest Med"},{"issue":"6","key":"2924_CR213","first-page":"2977","volume":"24","author":"JZ Wu","year":"2020","unstructured":"Wu JZ, et al. STYXL1 promotes malignant progression of hepatocellular carcinoma via downregulating CELF2 through the PI3K\/Akt pathway. Eur Rev Med Pharmacol Sci. 2020;24(6):2977\u201385.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"2924_CR214","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41419-020-02853-8","volume":"11","author":"SC Xie","year":"2020","unstructured":"Xie SC, et al. LncRNA CRNDE facilitates epigenetic suppression of CELF2 and LATS2 to promote proliferation, migration and chemoresistance in hepatocellular carcinoma. Cell Death Dis. 2020;11(8):676.","journal-title":"Cell Death Dis"},{"key":"2924_CR215","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejphar.2014.02.002","volume":"728","author":"Z Xiao","year":"2014","unstructured":"Xiao Z, et al. Role of microRNA-95 in the anticancer activity of Brucein D in hepatocellular carcinoma. Eur J Pharmacol. 2014;728:141\u201350.","journal-title":"Eur J Pharmacol"},{"key":"2924_CR216","first-page":"1","volume":"149","author":"S Chidambaranathan-Reghupaty","year":"2021","unstructured":"Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv Cancer Res. 2021;149:1\u201361.","journal-title":"Adv Cancer Res"},{"key":"2924_CR217","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119288","volume":"275","author":"C Liu","year":"2021","unstructured":"Liu C, et al. LncRNA BACE1-AS enhances the invasive and metastatic capacity of hepatocellular carcinoma cells through mediating miR-377-3p\/CELF1 axis. Life Sci. 2021;275:119288.","journal-title":"Life Sci"},{"issue":"1","key":"2924_CR218","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12967-019-02140-x","volume":"17","author":"Y-X Hu","year":"2019","unstructured":"Hu Y-X, et al. Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer. J Transl Med. 2019;17(1):379.","journal-title":"J Transl Med"},{"issue":"1","key":"2924_CR219","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12935-020-01299-4","volume":"20","author":"D Ouyang","year":"2020","unstructured":"Ouyang D, et al. Comprehensive analysis of prognostic alternative splicing signature in cervical cancer. Cancer Cell Int. 2020;20(1):221.","journal-title":"Cancer Cell Int"},{"issue":"9","key":"2924_CR220","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.bbagrm.2017.07.004","volume":"1860","author":"H Xia","year":"2017","unstructured":"Xia H, et al. CELF1 preferentially binds to exon-intron boundary and regulates alternative splicing in HeLa cells. Biochim Biophys Acta Gene Regul Mech. 2017;1860(9):911\u201321.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"2924_CR221","doi-asserted-by":"publisher","first-page":"1086835","DOI":"10.3389\/fcell.2022.1086835","volume":"10","author":"J Kang","year":"2022","unstructured":"Kang J, et al. Angiogenesis-related gene signatures reveal the prognosis of cervical cancer based on single cell sequencing and co-expression network analysis. Front Cell Dev Biol. 2022;10:1086835.","journal-title":"Front Cell Dev Biol"},{"key":"2924_CR222","doi-asserted-by":"publisher","first-page":"7933","DOI":"10.2147\/IJGM.S335475","volume":"14","author":"X Wang","year":"2021","unstructured":"Wang X, et al. Prognostic significance of alternative splicing genes in cervical squamous cell carcinoma and endocervical adenocarcinoma. Int J Gen Med. 2021;14:7933\u201349.","journal-title":"Int J Gen Med"},{"issue":"19","key":"2924_CR223","doi-asserted-by":"publisher","first-page":"31758","DOI":"10.18632\/oncotarget.15970","volume":"8","author":"J Fang","year":"2017","unstructured":"Fang J, et al. Correlation between polymorphisms in microRNA-regulated genes and cervical cancer susceptibility in a Xinjiang Uygur population. Oncotarget. 2017;8(19):31758\u201364.","journal-title":"Oncotarget"},{"issue":"1","key":"2924_CR224","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4149\/neo_2022_220907N908","volume":"70","author":"WY Jin","year":"2023","unstructured":"Jin WY, et al. HOXA5 inhibits the proliferation and metastasis of cervical squamous cell carcinoma by suppressing the \u03b2-catenin\/Snail signaling. Neoplasma. 2023;70(1):82\u201393.","journal-title":"Neoplasma"},{"key":"2924_CR225","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.626858","volume":"11","author":"Z Fan","year":"2021","unstructured":"Fan Z, et al. Genome-wide analyses of prognostic and therapeutic alternative splicing signatures in bladder urothelial carcinoma. Front Oncol. 2021;11:626858.","journal-title":"Front Oncol"},{"issue":"1","key":"2924_CR226","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1038\/s41467-017-02353-y","volume":"8","author":"M Cifdaloz","year":"2017","unstructured":"Cifdaloz M, et al. Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1. Nat Commun. 2017;8(1):2249.","journal-title":"Nat Commun"},{"key":"2924_CR227","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.3389\/fonc.2020.01740","volume":"10","author":"R Cao","year":"2020","unstructured":"Cao R, et al. Comprehensive analysis of prognostic alternative splicing signatures in oral squamous cell carcinoma. Front Oncol. 2020;10:1740.","journal-title":"Front Oncol"},{"key":"2924_CR228","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.738978","volume":"9","author":"DL Shi","year":"2021","unstructured":"Shi DL, Grifone R. RNA-binding proteins in the post-transcriptional control of skeletal muscle development, regeneration and disease. Front Cell Dev Biol. 2021;9:738978.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"2924_CR229","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S1050-1738(03)00075-6","volume":"13","author":"K Musunuru","year":"2003","unstructured":"Musunuru K. Cell-specific RNA-binding proteins in human disease. Trends Cardiovasc Med. 2003;13(5):188\u201395.","journal-title":"Trends Cardiovasc Med"},{"issue":"13","key":"2924_CR230","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.3390\/ijms20133365","volume":"20","author":"\u0141J Sznajder","year":"2019","unstructured":"Sznajder \u0141J, Swanson MS. Short tandem repeat expansions and RNA-mediated pathogenesis in Myotonic Dystrophy. Int J Mol Sci. 2019;20(13):3365.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2924_CR231","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bbadis.2014.05.019","volume":"1852","author":"G Meola","year":"2015","unstructured":"Meola G, Cardani R. Myotonic dystrophies: an update on clinical aspects, genetic, pathology, and molecular pathomechanisms. Biochim Biophys Acta Mol Basis Dis. 2015;1852(4):594\u2013606.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"2924_CR232","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/jnr.20980","volume":"84","author":"O Leroy","year":"2006","unstructured":"Leroy O, et al. ETR-3 represses Tau exons 2\/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I. J Neurosci Res. 2006;84(4):852\u20139.","journal-title":"J Neurosci Res"},{"issue":"7","key":"2924_CR233","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.bbadis.2011.03.010","volume":"1812","author":"CM Dhaenens","year":"2011","unstructured":"Dhaenens CM, et al. Mis-splicing of Tau exon 10 in Myotonic Dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing. Biochim Biophys Acta. 2011;1812(7):732\u201342.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"2924_CR234","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1172\/JCI32308","volume":"117","author":"GS Wang","year":"2007","unstructured":"Wang GS, et al. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy. J Clin Invest. 2007;117(10):2802\u201311.","journal-title":"J Clin Invest"},{"issue":"6","key":"2924_CR235","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/hmg\/ddp570","volume":"19","author":"M Koshelev","year":"2010","unstructured":"Koshelev M, et al. Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of Myotonic Dystrophy type 1. Hum Mol Genet. 2010;19(6):1066\u201375.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"2924_CR236","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.devcel.2020.01.037","volume":"52","author":"C Misra","year":"2020","unstructured":"Misra C, et al. Aberrant expression of a non-muscle RBFOX2 isoform triggers cardiac conduction defects in Myotonic Dystrophy. Dev Cell. 2020;52(6):748-763.e6.","journal-title":"Dev Cell"},{"issue":"3","key":"2924_CR237","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/dvdy.24240","volume":"244","author":"A Chau","year":"2015","unstructured":"Chau A, Kalsotra A. Developmental insights into the pathology of and therapeutic strategies for DM1: back to the basics. Dev Dyn. 2015;244(3):377\u201390.","journal-title":"Dev Dyn"},{"issue":"2","key":"2924_CR238","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/hmg\/ddt419","volume":"23","author":"YK Kim","year":"2014","unstructured":"Kim YK, et al. Evaluating the effects of CELF1 deficiency in a mouse model of RNA toxicity. Hum Mol Genet. 2014;23(2):293\u2013302.","journal-title":"Hum Mol Genet"},{"issue":"18","key":"2924_CR239","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1093\/hmg\/ddq277","volume":"19","author":"AJ Ward","year":"2010","unstructured":"Ward AJ, et al. CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1. Hum Mol Genet. 2010;19(18):3614\u201322.","journal-title":"Hum Mol Genet"},{"key":"2924_CR240","doi-asserted-by":"publisher","DOI":"10.1371\/currents.RRN1305","volume":"4","author":"DS Berger","year":"2012","unstructured":"Berger DS, Ladd AN. Repression of nuclear CELF activity can rescue CELF-regulated alternative splicing defects in skeletal muscle models of myotonic dystrophy. PLoS Curr. 2012;4:Rrn1305.","journal-title":"PLoS Curr"},{"key":"2924_CR241","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1750-1172-6-71","volume":"6","author":"A D'Amico","year":"2011","unstructured":"D\u2019Amico A, et al. Spinal muscular atrophy. Orphanet J Rare Dis. 2011;6:71.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"2924_CR242","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.nmd.2004.08.009","volume":"14","author":"KN Anderson","year":"2004","unstructured":"Anderson KN, et al. Expression profiling in spinal muscular atrophy reveals an RNA binding protein deficit. Neuromuscul Disord. 2004;14(11):711\u201322.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"2924_CR243","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","volume":"11","author":"AA Tahami Monfared","year":"2022","unstructured":"Tahami Monfared AA, et al. Alzheimer\u2019s disease: epidemiology and clinical progression. Neurol Ther. 2022;11(2):553\u201369.","journal-title":"Neurol Ther"},{"key":"2924_CR244","doi-asserted-by":"publisher","first-page":"1178588","DOI":"10.3389\/fneur.2023.1178588","volume":"14","author":"RS Madnani","year":"2023","unstructured":"Madnani RS. Alzheimer\u2019s disease: a mini-review for the clinician. Front Neurol. 2023;14:1178588.","journal-title":"Front Neurol"},{"key":"2924_CR245","doi-asserted-by":"publisher","first-page":"1237874","DOI":"10.3389\/fnmol.2023.1237874","volume":"16","author":"ME Farhadieh","year":"2023","unstructured":"Farhadieh ME, Ghaedi K. Analyzing alternative splicing in Alzheimer\u2019s disease postmortem brain: a cell-level perspective. Front Mol Neurosci. 2023;16:1237874.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"2924_CR246","doi-asserted-by":"publisher","first-page":"17995","DOI":"10.1038\/s41598-020-75057-x","volume":"10","author":"M Yanaizu","year":"2020","unstructured":"Yanaizu M, et al. CELF2 regulates the species-specific alternative splicing of TREM2. Sci Rep. 2020;10(1):17995.","journal-title":"Sci Rep"},{"issue":"1","key":"2924_CR247","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3233\/ADR-230072","volume":"7","author":"Y Ding","year":"2023","unstructured":"Ding Y, et al. Relationship between FERMT2, CELF1, COPI, CHRNA2, and ABCA7 genetic polymorphisms and Alzheimer\u2019s disease risk in the Southern Chinese population. J Alzheimers Dis Rep. 2023;7(1):1247\u201357.","journal-title":"J Alzheimers Dis Rep"},{"key":"2924_CR248","doi-asserted-by":"crossref","unstructured":"Hinney A, et al. Genetic variation at the CELF1 (CUGBP, elav-like family member 1 gene) locus is genome-wide associated with Alzheimer's disease and obesity. Am J Med Genet B Neuropsychiatr Genet. 2014;165b(4):283\u201393.","DOI":"10.1002\/ajmg.b.32234"},{"issue":"7","key":"2924_CR249","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1073\/pnas.1307345111","volume":"111","author":"T Morihara","year":"2014","unstructured":"Morihara T, et al. Transcriptome analysis of distinct mouse strains reveals kinesin light chain-1 splicing as an amyloid-\u03b2 accumulation modifier. Proc Natl Acad Sci U S A. 2014;111(7):2638\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2924_CR250","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150025","volume":"721","author":"M Kikuchi","year":"2024","unstructured":"Kikuchi M, et al. Gene-gene functional relationships in Alzheimer\u2019s disease: CELF1 regulates KLC1 alternative splicing. Biochem Biophys Res Commun. 2024;721:150025.","journal-title":"Biochem Biophys Res Commun"},{"key":"2924_CR251","doi-asserted-by":"crossref","unstructured":"Dhaenens CM, et al. Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing. Biochim Biophys Acta Mol Basis Dis. 2011;1812(7):732\u2013742.","DOI":"10.1016\/j.bbadis.2011.03.010"},{"key":"2924_CR252","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.755392","volume":"13","author":"J Liu","year":"2021","unstructured":"Liu J, et al. Brain pathogenesis and potential therapeutic strategies in Myotonic Dystrophy Type 1. Front Aging Neurosci. 2021;13:755392.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"2924_CR253","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.03.003","volume":"85","author":"PN Banerjee","year":"2009","unstructured":"Banerjee PN, Filippi D, Hauser WA. The descriptive epidemiology of epilepsy-a review. Epilepsy Res. 2009;85(1):31\u201345.","journal-title":"Epilepsy Res"},{"issue":"6","key":"2924_CR254","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1111\/epi.18338","volume":"66","author":"S Beniczky","year":"2025","unstructured":"Beniczky S, et al. Updated classification of epileptic seizures: position paper of the International League Against Epilepsy. Epilepsia. 2025;66(6):1804\u201323.","journal-title":"Epilepsia"},{"key":"2924_CR255","doi-asserted-by":"crossref","unstructured":"Donnellan EP, et al. The 2017 and 2022 ILAE epilepsy classification systems identify needs and opportunities in care: a paediatric hospital-based study. Epilepsy Behav. 2024;157:109804.","DOI":"10.1016\/j.yebeh.2024.109804"},{"issue":"7","key":"2924_CR256","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0030124","volume":"3","author":"Y Yang","year":"2007","unstructured":"Yang Y, et al. Complex seizure disorder caused by Brunol4 deficiency in mice. PLoS Genet. 2007;3(7):e124.","journal-title":"PLoS Genet"},{"issue":"1","key":"2924_CR257","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1113\/jphysiol.2012.240168","volume":"591","author":"W Sun","year":"2013","unstructured":"Sun W, et al. Aberrant sodium channel activity in the complex seizure disorder of Celf4 mutant mice. J Physiol. 2013;591(1):241\u201355.","journal-title":"J Physiol"},{"key":"2924_CR259","doi-asserted-by":"publisher","unstructured":"Wang X, et al. Modeling epilepsy by loss-of-function of the CUG-binding protein Elav-like family member 2 in zebrafish with multi-omics analysis. Chinese Med J. 139(3):433\u201342. https:\/\/doi.org\/10.1097\/CM9.0000000000003398.","DOI":"10.1097\/CM9.0000000000003398"},{"issue":"1","key":"2924_CR260","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13052-022-01310-w","volume":"48","author":"N Salari","year":"2022","unstructured":"Salari N, et al. The global prevalence of autism spectrum disorder: a comprehensive systematic review and meta-analysis. Ital J Pediatr. 2022;48(1):112.","journal-title":"Ital J Pediatr"},{"issue":"3","key":"2924_CR261","first-page":"36","volume":"28","author":"M Guha","year":"2014","unstructured":"Guha M. Diagnostic and Statistical Manual of Mental Disorders: DSM-5 (5th edition). Ref Rev. 2014;28(3):36\u20137.","journal-title":"Ref Rev"},{"key":"2924_CR262","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/B978-0-12-418700-9.00003-4","volume":"113","author":"SE Maloney","year":"2013","unstructured":"Maloney SE, Rieger MA, Dougherty JD. Identifying essential cell types and circuits in autism spectrum disorders. Int Rev Neurobiol. 2013;113:61\u201396.","journal-title":"Int Rev Neurobiol"},{"key":"2924_CR263","doi-asserted-by":"crossref","unstructured":"Gilling M, et al. A 3.2 Mb deletion on 18q12 in a patient with childhood autism and high-grade myopia. Eur J Hum Genet. 2008;16(3):312\u20139.","DOI":"10.1038\/sj.ejhg.5201985"},{"issue":"9716","key":"2924_CR264","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(09)62023-7","volume":"375","author":"JL Jefferies","year":"2010","unstructured":"Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet. 2010;375(9716):752\u201362.","journal-title":"Lancet"},{"issue":"10092","key":"2924_CR265","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","volume":"390","author":"RG Weintraub","year":"2017","unstructured":"Weintraub RG, Semsarian C, Macdonald P. Dilated cardiomyopathy. Lancet. 2017;390(10092):400\u201314.","journal-title":"Lancet"},{"issue":"5","key":"2924_CR266","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002553R","volume":"35","author":"KT Chang","year":"2021","unstructured":"Chang KT, et al. CELF1 promotes vascular endothelial growth factor degradation resulting in impaired microvasculature in heart failure. FASEB J. 2021;35(5):e21512.","journal-title":"FASEB J"},{"key":"2924_CR267","doi-asserted-by":"crossref","unstructured":"Jeffrey DA, Sucharov CC. CELF1 regulates gap junction integrity contributing to dilated cardiomyopathy. Non-coding RNA Investig. 2018;2:10.","DOI":"10.21037\/ncri.2018.02.03"},{"issue":"4","key":"2924_CR268","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124462","volume":"10","author":"T Dasgupta","year":"2015","unstructured":"Dasgupta T, et al. Gene expression analyses during spontaneous reversal of cardiomyopathy in mice with repressed nuclear CUG-BP, Elav-Like Family (CELF) activity in heart muscle. PLoS ONE. 2015;10(4):e0124462.","journal-title":"PLoS ONE"},{"issue":"8","key":"2924_CR269","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1200\/JCO.2015.63.4550","volume":"34","author":"X Wang","year":"2016","unstructured":"Wang X, et al. CELF4 variant and anthracycline-related cardiomyopathy: a Children\u2019s Oncology Group genome-wide association study. J Clin Oncol. 2016;34(8):863\u201370.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2924_CR270","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s12872-025-04914-2","volume":"25","author":"X Zhang","year":"2025","unstructured":"Zhang X, et al. CUGBP Elav-like family member 4 promotes cardiac remodeling through inhibition of FMO2. BMC Cardiovasc Disord. 2025;25(1):454.","journal-title":"BMC Cardiovasc Disord"},{"key":"2924_CR271","doi-asserted-by":"publisher","first-page":"2579832","DOI":"10.1155\/2016\/2579832","volume":"2016","author":"A Galli","year":"2016","unstructured":"Galli A, Lombardi F. Postinfarct left ventricular remodelling: a prevailing cause of heart failure. Cardiol Res Pract. 2016;2016:2579832.","journal-title":"Cardiol Res Pract"},{"issue":"8","key":"2924_CR272","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3390\/life12081111","volume":"12","author":"SA Leanc\u0103","year":"2022","unstructured":"Leanc\u0103 SA, et al. Left ventricular remodeling after myocardial infarction: from physiopathology to treatment. Life. 2022;12(8):1111.","journal-title":"Life"},{"key":"2924_CR273","doi-asserted-by":"publisher","first-page":"3920195","DOI":"10.1155\/2017\/3920195","volume":"2017","author":"L Schirone","year":"2017","unstructured":"Schirone L, et al. A review of the molecular mechanisms underlying the development and progression of cardiac remodeling. Oxid Med Cell Longev. 2017;2017:3920195.","journal-title":"Oxid Med Cell Longev"},{"key":"2924_CR274","volume-title":"Insulin resistance","author":"AM Freeman","year":"2025","unstructured":"Freeman AM, Acevedo LA, Pennings N. Insulin resistance. Treasure Island (FL): StatPearls Publishing; 2025."},{"issue":"1","key":"2924_CR275","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12916-019-1440-4","volume":"17","author":"Q Wang","year":"2019","unstructured":"Wang Q, et al. Insulin resistance and systemic metabolic changes in oral glucose tolerance test in 5340 individuals: an interventional study. BMC Med. 2019;17(1):217.","journal-title":"BMC Med"},{"key":"2924_CR276","doi-asserted-by":"publisher","first-page":"1591677","DOI":"10.3389\/fendo.2025.1591677","volume":"16","author":"U Aliyu","year":"2025","unstructured":"Aliyu U, et al. Evaluating indices of insulin resistance and estimating the prevalence of insulin resistance in a large biobank cohort. Front Endocrinol (Lausanne). 2025;16:1591677.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"18","key":"2924_CR277","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1038\/sj.emboj.7601296","volume":"25","author":"S Paul","year":"2006","unstructured":"Paul S, et al. Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. Embo j. 2006;25(18):4271\u201383.","journal-title":"Embo j"},{"issue":"9","key":"2924_CR278","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/carcin\/bgz141","volume":"41","author":"G Huang","year":"2020","unstructured":"Huang G, et al. RNA-binding protein CUGBP1 controls the differential INSR splicing in molecular subtypes of breast cancer cells and affects cell aggressiveness. Carcinogenesis. 2020;41(9):1294\u2013305.","journal-title":"Carcinogenesis"},{"issue":"9","key":"2924_CR279","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s00125-016-4005-5","volume":"59","author":"K Zhai","year":"2016","unstructured":"Zhai K, et al. RNA-binding protein CUGBP1 regulates insulin secretion via activation of phosphodiesterase 3B in mice. Diabetologia. 2016;59(9):1959\u201367.","journal-title":"Diabetologia"},{"issue":"32","key":"2924_CR280","doi-asserted-by":"publisher","first-page":"23025","DOI":"10.1074\/jbc.M513187200","volume":"281","author":"I Karagiannides","year":"2006","unstructured":"Karagiannides I, et al. Increased CUG triplet repeat-binding protein-1 predisposes to impaired adipogenesis with aging. J Biol Chem. 2006;281(32):23025\u201333.","journal-title":"J Biol Chem"},{"key":"2924_CR281","doi-asserted-by":"publisher","unstructured":"Nutter CA, Kuyumcu-Martinez MN, Emerging roles of RNA-binding proteins in diabetes and their therapeutic potential in diabetic complications. Wiley Interdiscip Rev RNA. 2018;9(2). https:\/\/doi.org\/10.1002\/wrna.1459.","DOI":"10.1002\/wrna.1459"},{"issue":"1","key":"2924_CR282","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/ng704","volume":"29","author":"RS Savkur","year":"2001","unstructured":"Savkur RS, Philips AV, Cooper TA. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in Myotonic dystrophy. Nat Genet. 2001;29(1):40\u20137.","journal-title":"Nat Genet"},{"key":"2924_CR283","doi-asserted-by":"publisher","DOI":"10.1038\/srep31222","volume":"6","author":"P Malakar","year":"2016","unstructured":"Malakar P, et al. Insulin receptor alternative splicing is regulated by insulin signaling and modulates beta cell survival. Sci Rep. 2016;6:31222.","journal-title":"Sci Rep"},{"key":"2924_CR284","doi-asserted-by":"crossref","unstructured":"Izzo M, et al. Molecular therapies for Myotonic Dystrophy Type 1: from small drugs to gene editing. Int J Mol Sci. 2022;23(9):4622.","DOI":"10.3390\/ijms23094622"},{"issue":"1","key":"2924_CR285","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.molcel.2007.07.027","volume":"28","author":"NM Kuyumcu-Martinez","year":"2007","unstructured":"Kuyumcu-Martinez NM, Wang GS, Cooper TA. Increased steady-state levels of CUGBP1 in Myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol Cell. 2007;28(1):68\u201378.","journal-title":"Mol Cell"},{"issue":"12","key":"2924_CR286","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1172\/JCI37976","volume":"119","author":"GS Wang","year":"2009","unstructured":"Wang GS, et al. PKC inhibition ameliorates the cardiac phenotype in a mouse model of Myotonic dystrophy type 1. J Clin Invest. 2009;119(12):3797\u2013806.","journal-title":"J Clin Invest"},{"key":"2924_CR287","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.omtn.2023.05.007","volume":"32","author":"F Porquet","year":"2023","unstructured":"Porquet F, et al. Specific DMPK-promoter targeting by CRISPRi reverses Myotonic dystrophy type 1-associated defects in patient muscle cells. Mol Ther Nucleic Acids. 2023;32:857\u201371.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"11","key":"2924_CR288","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1080\/17568919.2025.2520152","volume":"17","author":"P Mundlia","year":"2025","unstructured":"Mundlia P, et al. RNA-targeting therapeutics: drugging the undruggable. Future Med Chem. 2025;17(11):1213\u20135.","journal-title":"Future Med Chem"},{"key":"2924_CR289","doi-asserted-by":"crossref","unstructured":"Pozdniakova N, et al. RNA therapeutics: delivery problems and solutions-a review. Pharmaceutics. 2025;17(10):1305.","DOI":"10.3390\/pharmaceutics17101305"},{"key":"2924_CR290","doi-asserted-by":"crossref","unstructured":"Shahid U. Advances in RNA therapeutics: classes, innovations and clinical applications, in preprints. 2025, Preprints.","DOI":"10.20944\/preprints202504.0866.v1"},{"key":"2924_CR291","doi-asserted-by":"crossref","unstructured":"Lee HJ, et al. Prospective evaluation of cervical scrapings CDO1 and CELF4 methylation (epiHERA(\u00ae)) assay in detection of endometrial cancer. Cancers (Basel). 2025;17(18):3010.","DOI":"10.3390\/cancers17183010"},{"key":"2924_CR292","doi-asserted-by":"publisher","first-page":"1289366","DOI":"10.3389\/fonc.2023.1289366","volume":"13","author":"B Qi","year":"2023","unstructured":"Qi B, et al. Hypermethylated CDO1 and CELF4 in cytological specimens as triage strategy biomarkers in endometrial malignant lesions. Front Oncol. 2023;13:1289366.","journal-title":"Front Oncol"},{"issue":"11","key":"2924_CR293","doi-asserted-by":"publisher","first-page":"4739","DOI":"10.1172\/JCI128205","volume":"129","author":"AF Klein","year":"2019","unstructured":"Klein AF, et al. Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice. J Clin Invest. 2019;129(11):4739\u201344.","journal-title":"J Clin Invest"},{"issue":"5","key":"2924_CR294","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.celrep.2019.06.079","volume":"28","author":"C Jiang","year":"2019","unstructured":"Jiang C, et al. CRISPR\/Cas9 screens reveal multiple layers of B cell CD40 regulation. Cell Rep. 2019;28(5):1307-1322.e8.","journal-title":"Cell Rep"},{"issue":"1","key":"2924_CR295","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00018-013-1310-8","volume":"71","author":"L Gherardini","year":"2014","unstructured":"Gherardini L, et al. Novel siRNA delivery strategy: a new \u201cstrand\u201d in CNS translational medicine? Cell Mol Life Sci. 2014;71(1):1\u201320.","journal-title":"Cell Mol Life Sci"},{"key":"2924_CR296","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.brainresbull.2019.05.024","volume":"150","author":"DL Puhl","year":"2019","unstructured":"Puhl DL, D\u2019Amato AR, Gilbert RJ. Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors. Brain Res Bull. 2019;150:216\u201330.","journal-title":"Brain Res Bull"},{"issue":"1","key":"2924_CR297","first-page":"6","volume":"1","author":"R Xie","year":"2023","unstructured":"Xie R, et al. Non-viral approaches for gene therapy and therapeutic genome editing across the blood-brain barrier. Med X. 2023;1(1):6.","journal-title":"Med X"},{"issue":"1","key":"2924_CR298","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/bfgp\/elm005","volume":"6","author":"A Jagannath","year":"2007","unstructured":"Jagannath A, Wood M. RNA interference based gene therapy for neurological disease. Brief Funct Genomics Proteomics. 2007;6(1):40\u20139.","journal-title":"Brief Funct Genomics Proteomics"},{"issue":"1","key":"2924_CR299","first-page":"2","volume":"5","author":"C Sousa","year":"2025","unstructured":"Sousa C, Videira M. Dual approaches in oncology: the promise of siRNA and chemotherapy combinations in cancer therapies. Oncogene. 2025;5(1):2.","journal-title":"Oncogene"},{"issue":"7","key":"2924_CR300","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.drudis.2021.03.024","volume":"26","author":"M Pascual-Gilabert","year":"2021","unstructured":"Pascual-Gilabert M, L\u00f3pez-Castel A, Artero R. Myotonic Dystrophy type 1 drug development: a pipeline toward the market. Drug Discov Today. 2021;26(7):1765\u201372.","journal-title":"Drug Discov Today"},{"key":"2924_CR301","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.omtn.2017.05.007","volume":"7","author":"D Jauvin","year":"2017","unstructured":"Jauvin D, et al. Targeting DMPK with antisense oligonucleotide improves muscle strength in Myotonic Dystrophy type 1 mice. Mol Ther Nucleic Acids. 2017;7:465\u201374.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2924_CR302","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3389\/fneur.2018.00519","volume":"9","author":"SO Braz","year":"2018","unstructured":"Braz SO, et al. Of Mice and Men: Advances in the Understanding of Neuromuscular Aspects of Myotonic Dystrophy. Front Neurol. 2018;9:519.","journal-title":"Front Neurol"},{"issue":"3","key":"2924_CR303","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S1474-4422(23)00001-7","volume":"22","author":"CA Thornton","year":"2023","unstructured":"Thornton CA, et al. Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1\/2a trial. Lancet Neurol. 2023;22(3):218\u201328.","journal-title":"Lancet Neurol"},{"key":"2924_CR304","unstructured":"Marisa Wexler and MS. MDA 2025: DYNE-101 improves finger function in DM1 clinical trial. 2025. Available from: https:\/\/musculardystrophynews.com\/news\/mda-2025-dyne-101-improves-finger-function-dm1-achieve-trial\/."},{"key":"2924_CR305","unstructured":"Johnson1 N, et al. Initial Results of the Phase 2 Open-Label Extension Study of AOC 1001 in Adults With Myotonic Dystrophy Type 1: MARINA-OLE. 2024."},{"issue":"5","key":"2924_CR306","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1093\/nar\/gkac139","volume":"50","author":"Y Tan","year":"2022","unstructured":"Tan Y, et al. Small molecule targeting CELF1 RNA-binding activity to control HSC activation and liver fibrosis. Nucleic Acids Res. 2022;50(5):2440\u201351.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2924_CR307","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1877","volume":"15","author":"S Schmeing","year":"2024","unstructured":"Schmeing S, Hart P. Challenges in therapeutically targeting the RNA-recognition motif. Wiley Interdiscip Rev RNA. 2024;15(6):e1877.","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"18","key":"2924_CR308","doi-asserted-by":"publisher","first-page":"10810","DOI":"10.1093\/nar\/gkae788","volume":"52","author":"Y Tan","year":"2024","unstructured":"Tan Y, et al. Identification of an RNA-binding perturbing characteristic for thiopurine drugs and their derivatives to disrupt CELF1-RNA interaction. Nucleic Acids Res. 2024;52(18):10810\u201322.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2924_CR309","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103580","volume":"28","author":"JB Bertoldo","year":"2023","unstructured":"Bertoldo JB, M\u00fcller S, H\u00fcttelmaier S. RNA-binding proteins in cancer drug discovery. Drug Discov Today. 2023;28(6):103580.","journal-title":"Drug Discov Today"},{"issue":"10","key":"2924_CR310","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/s41557-023-01309-8","volume":"15","author":"L Fang","year":"2023","unstructured":"Fang L, et al. Pervasive transcriptome interactions of protein-targeted drugs. Nat Chem. 2023;15(10):1374\u201383.","journal-title":"Nat Chem"},{"key":"2924_CR311","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2025.1649692","volume":"13","author":"OM Konde","year":"2025","unstructured":"Konde OM, Balela WB, Tshitenge TB. Targeting RNA-binding proteins with small molecules: perspectives and challenges. Front Chem. 2025;13:1649692.","journal-title":"Front Chem"},{"issue":"1","key":"2924_CR312","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","volume":"9","author":"W Dai","year":"2024","unstructured":"Dai W, et al. Epigenetics-targeted drugs: current paradigms and future challenges. Signal Transduct Target Ther. 2024;9(1):332.","journal-title":"Signal Transduct Target Ther"},{"key":"2924_CR313","doi-asserted-by":"crossref","unstructured":"Lei Y, Lai M. Epigenetic regulation and therapeutic targeting of alternative splicing dysregulation in cancer. Pharmaceuticals (Basel). 2025;18(5):713.","DOI":"10.3390\/ph18050713"},{"key":"2924_CR314","unstructured":"Whitten A. Epigenetic editing expands the reach of gene therapy Rather than permanently cutting DNA, this new kind of gene therapy instead aims to regulate gene expression using epigenetic mechanisms. 2025; Available from: https:\/\/www.drugdiscoverynews.com\/epigenetic-editing-expands-the-reach-of-gene-therapy-16421."},{"issue":"1","key":"2924_CR315","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41420-024-01803-z","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu X, et al. Cancer epigenetics: from laboratory studies and clinical trials to precision medicine. Cell Death Discov. 2024;10(1):28.","journal-title":"Cell Death Discov"},{"issue":"6","key":"2924_CR316","doi-asserted-by":"publisher","first-page":"6933","DOI":"10.1096\/fj.201802547R","volume":"33","author":"MJ Saul","year":"2019","unstructured":"Saul MJ, et al. miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction. Faseb J. 2019;33(6):6933\u201347.","journal-title":"Faseb J"},{"issue":"3","key":"2924_CR317","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1021\/acs.jmedchem.6c00070","volume":"69","author":"C Kang","year":"2026","unstructured":"Kang C, et al. Small-molecule drug discovery targeting RNAs: hope or hype? J Med Chem. 2026;69(3):1786\u20139.","journal-title":"J Med Chem"},{"issue":"8","key":"2924_CR318","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1158\/2159-8290.CD-12-0191","volume":"2","author":"M Sen","year":"2012","unstructured":"Sen M, et al. First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy. Cancer Discov. 2012;2(8):694\u2013705.","journal-title":"Cancer Discov"},{"issue":"2","key":"2924_CR319","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41551-021-00838-2","volume":"6","author":"L Arandel","year":"2022","unstructured":"Arandel L, et al. Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats. Nat Biomed Eng. 2022;6(2):207\u201320.","journal-title":"Nat Biomed Eng"},{"issue":"13","key":"2924_CR320","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310650","volume":"24","author":"M Lutz","year":"2023","unstructured":"Lutz M, et al. Therapeutic targeting of the GSK3\u03b2-CUGBP1 pathway in myotonic dystrophy. Int J Mol Sci. 2023;24(13):10650.","journal-title":"Int J Mol Sci"},{"key":"2924_CR321","doi-asserted-by":"crossref","unstructured":"Halgren C, et al. Haploinsufficiency of CELF4 at 18q12.2 is associated with developmental and behavioral disorders, seizures, eye manifestations, and obesity. Eur J Hum Genet, 2012;20(12):1315\u20131319.","DOI":"10.1038\/ejhg.2012.92"},{"key":"2924_CR322","doi-asserted-by":"crossref","unstructured":"Vlasova-St. Louis I, et al. CELFish ways to modulate mRNA decay. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2013;1829(6):695\u2013707.","DOI":"10.1016\/j.bbagrm.2013.01.001"},{"key":"2924_CR323","doi-asserted-by":"publisher","unstructured":"House RP, et al. RNA-binding protein CELF1 promotes tumor growth and alters gene expression in oral squamous cell carcinoma. Oncotarget. 2015;6(41):43620\u201334. https:\/\/doi.org\/10.18632\/oncotarget.6204.","DOI":"10.18632\/oncotarget.6204"},{"issue":"17","key":"2924_CR324","doi-asserted-by":"publisher","first-page":"E2139","DOI":"10.1073\/pnas.1423695112","volume":"112","author":"MJ Mallory","year":"2015","unstructured":"Mallory MJ, et al. Induced transcription and stability of CELF2 mRNA drives widespread alternative splicing during T-cell signaling. Proc Natl Acad Sci U S A. 2015;112(17):E2139\u201348.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2924_CR325","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fimmu.2019.00021","volume":"10","author":"L Avelar","year":"2019","unstructured":"Avelar L, et al. Smp38 MAP kinase regulation in Schistosoma mansoni: roles in survival, oviposition, and protection against oxidative stress. Front Immunol. 2019;10:21.","journal-title":"Front Immunol"},{"issue":"1","key":"2924_CR326","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170680","volume":"12","author":"J Russo","year":"2017","unstructured":"Russo J, et al. The CELF1 RNA-binding protein regulates decay of signal recognition particle mRNAs and limits secretion in mouse myoblasts. PLoS ONE. 2017;12(1):e0170680.","journal-title":"PLoS ONE"},{"issue":"1","key":"2924_CR327","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s43586-021-00018-1","volume":"1","author":"M Hafner","year":"2021","unstructured":"Hafner M, et al. CLIP and complementary methods. Nat Rev Methods Primers. 2021;1(1):20.","journal-title":"Nat Rev Methods Primers"},{"issue":"7","key":"2924_CR328","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/s41592-024-02298-3","volume":"21","author":"FJ Pardo-Palacios","year":"2024","unstructured":"Pardo-Palacios FJ, et al. Systematic assessment of long-read RNA-seq methods for transcript identification and quantification. Nat Methods. 2024;21(7):1349\u201363.","journal-title":"Nat Methods"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02924-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02924-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02924-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:07:20Z","timestamp":1782950840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02924-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":327,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2924"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02924-x","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}